BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1370256	Cn1c2c(CCCOCCOCCNC(=O)[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4coc(n4)-c4ccnc(NCC5CC5)c4)c(n3)C(F)F)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:16.15,wD:19.22,(14.59,-4.98,;15.68,-3.89,;15.36,-2.38,;14.03,-1.61,;12.69,-2.38,;11.36,-1.61,;10.02,-2.38,;8.69,-1.61,;7.36,-2.38,;6.02,-1.61,;4.69,-2.38,;3.36,-1.61,;2.02,-2.38,;.69,-1.61,;-.65,-2.38,;-.65,-3.92,;-1.98,-1.61,;-3.31,-2.38,;-4.65,-1.61,;-4.65,-.07,;-3.31,.7,;-1.98,-.07,;-5.98,.7,;-7.44,.22,;-8.35,1.47,;-9.89,1.47,;-10.66,.14,;-9.89,-1.2,;-12.2,.14,;-13.11,1.38,;-14.57,.91,;-14.57,-.63,;-13.11,-1.11,;-15.66,-1.72,;-15.26,-3.21,;-16.35,-4.3,;-17.84,-3.9,;-18.24,-2.41,;-19.72,-2.02,;-20.81,-3.1,;-22.3,-2.71,;-23.39,-1.62,;-23.79,-3.1,;-17.15,-1.33,;-7.44,2.71,;-5.98,2.24,;-8.21,4.05,;-9.75,4.05,;-7.44,5.38,;14.03,-.07,;15.36,.7,;16.69,-.07,;16.69,-1.61,;17.84,-2.64,;19.32,-2.24,;20.41,-3.33,;21.9,-2.93,;22.3,-1.45,;23.79,-1.05,;21.21,-.36,;19.72,-.76,;18.63,.33,;17.21,-4.05,;17.98,-5.38,)|	InChI=1S/C44H52F2N10O8/c1-54-38-27(4-2-6-33(38)56(44(54)61)34-13-14-36(57)52-42(34)60)5-3-18-62-20-21-63-19-17-48-40(58)28-9-11-30(12-10-28)55-24-31(37(53-55)39(45)46)50-41(59)32-25-64-43(51-32)29-15-16-47-35(22-29)49-23-26-7-8-26/h2,4,6,15-16,22,24-26,28,30,34,39H,3,5,7-14,17-21,23H2,1H3,(H,47,49)(H,48,58)(H,50,59)(H,52,57,60)	MXYYLZOPONPYJN-UHFFFAOYSA-N	648378	US11352350, Compound I-1	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 300							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648378	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648378&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			159703935	494493246							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370257	Cn1c2c(CCCOCCOCCNC[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4coc(n4)-c4ccnc(NCC5CC5)c4)c(n3)C(F)F)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:15.14,wD:18.21,(14.59,-4.98,;15.68,-3.89,;15.36,-2.38,;14.03,-1.61,;12.69,-2.38,;11.36,-1.61,;10.02,-2.38,;8.69,-1.61,;7.36,-2.38,;6.02,-1.61,;4.69,-2.38,;3.36,-1.61,;2.02,-2.38,;.69,-1.61,;-.65,-2.38,;-1.98,-1.61,;-3.31,-2.38,;-4.65,-1.61,;-4.65,-.07,;-3.31,.7,;-1.98,-.07,;-5.98,.7,;-7.44,.22,;-8.35,1.47,;-9.89,1.47,;-10.66,.14,;-9.89,-1.2,;-12.2,.14,;-13.11,1.38,;-14.57,.91,;-14.57,-.63,;-13.11,-1.11,;-15.66,-1.72,;-15.26,-3.21,;-16.35,-4.3,;-17.84,-3.9,;-18.24,-2.41,;-19.72,-2.02,;-20.81,-3.1,;-22.3,-2.71,;-23.39,-1.62,;-23.79,-3.1,;-17.15,-1.33,;-7.44,2.71,;-5.98,2.24,;-8.21,4.05,;-9.75,4.05,;-7.44,5.38,;14.03,-.07,;15.36,.7,;16.69,-.07,;16.69,-1.61,;17.84,-2.64,;19.32,-2.24,;20.41,-3.33,;21.9,-2.93,;22.3,-1.45,;23.79,-1.05,;21.21,-.36,;19.72,-.76,;18.63,.33,;17.21,-4.05,;17.98,-5.38,)|	InChI=1S/C44H54F2N10O7/c1-54-39-29(4-2-6-34(39)56(44(54)60)35-13-14-37(57)52-42(35)59)5-3-18-61-20-21-62-19-17-47-23-27-9-11-31(12-10-27)55-25-32(38(53-55)40(45)46)50-41(58)33-26-63-43(51-33)30-15-16-48-36(22-30)49-24-28-7-8-28/h2,4,6,15-16,22,25-28,31,35,40,47H,3,5,7-14,17-21,23-24H2,1H3,(H,48,49)(H,50,58)(H,52,57,59)	DGGPDOJNQCUBOD-UHFFFAOYSA-N	648380	US11352350, Compound I-2	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648380	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648380&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733252	494493247							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370258	FC(F)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC2CC2)c1)[C@H]1CC[C@H](CNCCOCCOCCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)oc3c2)CC1 |r,wU:30.34,wD:27.30,(-8,2.06,;-6.46,2.06,;-5.69,3.4,;-5.69,.73,;-4.23,.25,;-4.23,-1.29,;-5.69,-1.76,;-6.6,-.52,;-8.14,-.52,;-8.91,-1.85,;-8.14,-3.19,;-10.45,-1.85,;-11.35,-3.1,;-12.82,-2.62,;-12.82,-1.08,;-11.35,-.61,;-14.15,-.31,;-14.15,1.23,;-15.48,2,;-16.82,1.23,;-16.82,-.31,;-18.15,-1.08,;-19.48,-.31,;-20.82,-1.08,;-22.36,-1.08,;-21.59,-2.42,;-15.48,-1.08,;-2.89,-2.06,;-2.89,-3.6,;-1.56,-4.37,;-.22,-3.6,;1.11,-4.37,;2.44,-3.6,;3.78,-4.37,;5.11,-3.6,;6.44,-4.37,;7.78,-3.6,;9.11,-4.37,;10.45,-3.6,;11.78,-4.37,;13.11,-3.6,;14.45,-4.37,;15.78,-3.6,;15.78,-2.06,;17.11,-1.29,;18.45,-2.06,;19.91,-1.58,;20.31,-.09,;21.8,.3,;22.2,1.79,;21.11,2.88,;21.51,4.37,;19.62,2.48,;19.22,.99,;17.73,.6,;20.82,-2.83,;22.36,-2.83,;19.91,-4.07,;18.45,-3.6,;17.11,-4.37,;-.22,-2.06,;-1.56,-1.29,)|	InChI=1S/C43H51F2N9O8/c44-39(45)38-31(49-40(56)32-25-61-42(50-32)29-13-14-47-36(21-29)48-23-28-3-4-28)24-53(52-38)30-8-5-27(6-9-30)22-46-15-17-60-19-18-59-16-1-2-26-7-10-33-35(20-26)62-43(58)54(33)34-11-12-37(55)51-41(34)57/h7,10,13-14,20-21,24-25,27-28,30,34,39,46H,1-6,8-9,11-12,15-19,22-23H2,(H,47,48)(H,49,56)(H,51,55,57)	BDALYIOECHOXDM-UHFFFAOYSA-N	648381	US11352350, Compound I-3	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648381	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648381&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			163446582	494493248							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370259	FC(F)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC2CC2)c1)[C@H]1CC[C@@H](CC1)C(=O)NCCOCCCc1cccc2n(C3CCC(=O)NC3=O)c(=O)oc12 |r,wU:30.37,wD:27.30,(-7.59,3.7,;-6.05,3.7,;-5.28,5.04,;-5.28,2.37,;-3.82,1.89,;-3.82,.35,;-5.28,-.12,;-6.19,1.12,;-7.73,1.12,;-8.5,-.21,;-7.73,-1.54,;-10.04,-.21,;-10.94,-1.46,;-12.41,-.98,;-12.41,.56,;-10.94,1.04,;-13.74,1.33,;-13.74,2.87,;-15.07,3.64,;-16.41,2.87,;-16.41,1.33,;-17.74,.56,;-19.08,1.33,;-20.41,.56,;-21.95,.56,;-21.18,-.77,;-15.07,.56,;-2.48,-.42,;-2.48,-1.96,;-1.15,-2.73,;.18,-1.96,;.18,-.42,;-1.15,.35,;1.52,-2.73,;1.52,-4.27,;2.85,-1.96,;4.18,-2.73,;5.52,-1.96,;6.85,-2.73,;8.19,-1.96,;9.52,-2.73,;10.85,-1.96,;12.19,-2.73,;12.19,-4.27,;13.52,-5.04,;14.85,-4.27,;14.85,-2.73,;16,-1.7,;17.49,-2.09,;18.58,-1.01,;20.06,-1.4,;20.46,-2.89,;21.95,-3.29,;19.37,-3.98,;17.88,-3.58,;16.8,-4.67,;15.37,-.29,;16.14,1.04,;13.84,-.45,;13.52,-1.96,)|	InChI=1S/C41H45F2N9O8/c42-36(43)34-28(47-38(55)29-22-59-40(48-29)26-14-15-44-32(19-26)46-20-23-6-7-23)21-51(50-34)27-10-8-25(9-11-27)37(54)45-16-18-58-17-2-4-24-3-1-5-30-35(24)60-41(57)52(30)31-12-13-33(53)49-39(31)56/h1,3,5,14-15,19,21-23,25,27,31,36H,2,4,6-13,16-18,20H2,(H,44,46)(H,45,54)(H,47,55)(H,49,53,56)	LUFKKCMYUWCSCT-UHFFFAOYSA-N	648383	US11352350, Compound I-5	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 300							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648383	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648383&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733856	494493249							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370260	Cn1c2c(CCCOCCOCCNC[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4coc(n4)-c4ccnc(NCC(F)(F)F)c4)c(n3)C(N)=O)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:18.21,wD:15.14,(-14.59,-4.98,;-15.68,-3.89,;-15.36,-2.38,;-14.03,-1.61,;-12.69,-2.38,;-11.36,-1.61,;-10.02,-2.38,;-8.69,-1.61,;-7.36,-2.38,;-6.02,-1.61,;-4.69,-2.38,;-3.36,-1.61,;-2.02,-2.38,;-.69,-1.61,;.65,-2.38,;1.98,-1.61,;3.31,-2.38,;4.65,-1.61,;4.65,-.07,;3.31,.7,;1.98,-.07,;5.98,.7,;7.44,.22,;8.35,1.47,;9.89,1.47,;10.66,.14,;9.89,-1.2,;12.2,.14,;13.11,1.38,;14.57,.91,;14.57,-.63,;13.11,-1.11,;15.66,-1.72,;15.26,-3.21,;16.35,-4.3,;17.84,-3.9,;18.24,-2.41,;19.72,-2.02,;20.81,-3.1,;22.3,-2.71,;23.39,-3.79,;22.7,-1.22,;23.79,-2.31,;17.15,-1.33,;7.44,2.71,;5.98,2.24,;8.21,4.05,;9.75,4.05,;7.44,5.38,;-14.03,-.07,;-15.36,.7,;-16.69,-.07,;-16.69,-1.61,;-17.84,-2.64,;-19.32,-2.24,;-20.41,-3.33,;-21.9,-2.93,;-22.3,-1.45,;-23.79,-1.05,;-21.21,-.36,;-19.72,-.76,;-18.63,.33,;-17.21,-4.05,;-17.98,-5.38,)|	InChI=1S/C42H50F3N11O8/c1-54-36-26(4-2-6-31(36)56(41(54)61)32-11-12-34(57)52-39(32)60)5-3-16-62-18-19-63-17-15-47-21-25-7-9-28(10-8-25)55-22-29(35(53-55)37(46)58)50-38(59)30-23-64-40(51-30)27-13-14-48-33(20-27)49-24-42(43,44)45/h2,4,6,13-14,20,22-23,25,28,32,47H,3,5,7-12,15-19,21,24H2,1H3,(H2,46,58)(H,48,49)(H,50,59)(H,52,57,60)	CEJRMXMJRBDHCS-UHFFFAOYSA-N	648384	US11352350, Compound I-6	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648384	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648384&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733704	494493250							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370261	NC(=O)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC(F)(F)F)c1)[C@H]1CC[C@H](CNCCOCCOCCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)oc3c2)CC1 |r,wU:28.30,wD:31.34,(8.1,2.06,;6.56,2.06,;5.79,3.4,;5.79,.73,;4.33,.25,;4.33,-1.29,;5.79,-1.76,;6.7,-.52,;8.24,-.52,;9.01,-1.85,;8.24,-3.19,;10.55,-1.85,;11.45,-3.1,;12.92,-2.62,;12.92,-1.08,;11.45,-.61,;14.25,-.31,;14.25,1.23,;15.59,2,;16.92,1.23,;16.92,-.31,;18.25,-1.08,;19.59,-.31,;20.92,-1.08,;22.25,-.31,;20.92,-2.62,;22.25,-1.85,;15.59,-1.08,;2.99,-2.06,;2.99,-3.6,;1.66,-4.37,;.33,-3.6,;-1.01,-4.37,;-2.34,-3.6,;-3.67,-4.37,;-5.01,-3.6,;-6.34,-4.37,;-7.67,-3.6,;-9.01,-4.37,;-10.34,-3.6,;-11.68,-4.37,;-13.01,-3.6,;-14.34,-4.37,;-15.68,-3.6,;-15.68,-2.06,;-17.01,-1.29,;-18.34,-2.06,;-19.81,-1.58,;-20.21,-.09,;-21.69,.3,;-22.09,1.79,;-21,2.88,;-21.4,4.37,;-19.52,2.48,;-19.12,.99,;-17.63,.6,;-20.71,-2.83,;-22.25,-2.83,;-19.81,-4.07,;-18.34,-3.6,;-17.01,-4.37,;.33,-2.06,;1.66,-1.29,)|	InChI=1S/C41H47F3N10O9/c42-41(43,44)23-48-33-19-26(11-12-47-33)39-50-29(22-62-39)37(57)49-28-21-53(52-35(28)36(45)56)27-6-3-25(4-7-27)20-46-13-15-61-17-16-60-14-1-2-24-5-8-30-32(18-24)63-40(59)54(30)31-9-10-34(55)51-38(31)58/h5,8,11-12,18-19,21-22,25,27,31,46H,1-4,6-7,9-10,13-17,20,23H2,(H2,45,56)(H,47,48)(H,49,57)(H,51,55,58)	TZXJISJYNJEEQU-UHFFFAOYSA-N	648385	US11352350, Compound I-7	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648385	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648385&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733863	494493251							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370262	Cn1c2cc(CCCOCCNC[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4coc(n4)-c4ccnc(NCC(F)(F)F)c4)c(n3)C(N)=O)ccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:16.19,wD:13.12,(-18.21,-2.06,;-17.81,-.58,;-16.34,-.1,;-15.01,-.87,;-13.68,-.1,;-12.34,-.87,;-11.01,-.1,;-9.68,-.87,;-8.34,-.1,;-7.01,-.87,;-5.67,-.1,;-4.34,-.87,;-3.01,-.1,;-1.67,-.87,;-1.67,-2.41,;-.34,-3.18,;.99,-2.41,;.99,-.87,;-.34,-.1,;2.33,-3.18,;3.79,-2.71,;4.7,-3.95,;6.24,-3.95,;7.01,-2.62,;6.24,-1.28,;8.55,-2.62,;9.45,-1.37,;10.92,-1.85,;10.92,-3.39,;9.45,-3.86,;12.25,-4.16,;12.25,-5.7,;13.59,-6.47,;14.92,-5.7,;14.92,-4.16,;16.25,-3.39,;17.59,-4.16,;18.92,-3.39,;20.25,-4.16,;18.92,-1.85,;20.25,-2.62,;13.59,-3.39,;3.79,-5.2,;2.33,-4.72,;4.56,-6.53,;6.1,-6.53,;3.79,-7.86,;-13.68,1.44,;-15.01,2.21,;-16.34,1.44,;-17.81,1.91,;-18.21,3.4,;-19.69,3.8,;-20.09,5.29,;-19,6.38,;-19.4,7.86,;-17.52,5.98,;-17.12,4.49,;-15.63,4.09,;-18.71,.67,;-20.25,.67,)|	InChI=1S/C40H46F3N11O7/c1-52-31-17-23(6-9-29(31)54(39(52)59)30-10-11-33(55)50-37(30)58)3-2-15-60-16-14-45-19-24-4-7-26(8-5-24)53-20-27(34(51-53)35(44)56)48-36(57)28-21-61-38(49-28)25-12-13-46-32(18-25)47-22-40(41,42)43/h6,9,12-13,17-18,20-21,24,26,30,45H,2-5,7-8,10-11,14-16,19,22H2,1H3,(H2,44,56)(H,46,47)(H,48,57)(H,50,55,58)	PECNHNUMYPENAK-UHFFFAOYSA-N	648386	US11352350, Compound I-8	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648386	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648386&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			160179672	494493252							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370263	Cn1c2cc(CCCCOCCCCNC[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4coc(n4)-c4ccnc(NCC(F)(F)F)c4)c(n3)C(N)=O)ccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:19.22,wD:16.15,(-20.15,-4.6,;-19.75,-3.11,;-18.28,-2.64,;-16.95,-3.41,;-15.62,-2.64,;-14.28,-3.41,;-12.95,-2.64,;-11.62,-3.41,;-10.28,-2.64,;-8.95,-3.41,;-7.62,-2.64,;-6.28,-3.41,;-4.95,-2.64,;-3.61,-3.41,;-2.28,-2.64,;-.95,-3.41,;.39,-2.64,;1.72,-3.41,;3.05,-2.64,;3.05,-1.1,;1.72,-.33,;.39,-1.1,;4.39,-.33,;5.85,-.8,;6.76,.44,;8.3,.44,;9.07,-.89,;8.3,-2.23,;10.61,-.89,;11.51,.35,;12.98,-.12,;12.98,-1.66,;11.51,-2.14,;14.07,-2.75,;13.67,-4.24,;14.76,-5.33,;16.24,-4.93,;16.64,-3.44,;18.13,-3.04,;19.22,-4.13,;20.71,-3.73,;21.8,-4.82,;21.11,-2.25,;22.19,-3.33,;15.55,-2.35,;5.85,1.69,;4.39,1.21,;6.62,3.02,;8.16,3.02,;5.85,4.35,;-15.62,-1.1,;-16.95,-.33,;-18.28,-1.1,;-19.75,-.62,;-20.15,.87,;-21.64,1.26,;-22.03,2.75,;-20.94,3.84,;-21.34,5.33,;-19.46,3.44,;-19.06,1.95,;-17.57,1.56,;-20.65,-1.87,;-22.19,-1.87,)|	InChI=1S/C43H52F3N11O7/c1-55-34-20-26(9-12-32(34)57(42(55)62)33-13-14-36(58)53-40(33)61)6-2-4-18-63-19-5-3-16-48-22-27-7-10-29(11-8-27)56-23-30(37(54-56)38(47)59)51-39(60)31-24-64-41(52-31)28-15-17-49-35(21-28)50-25-43(44,45)46/h9,12,15,17,20-21,23-24,27,29,33,48H,2-8,10-11,13-14,16,18-19,22,25H2,1H3,(H2,47,59)(H,49,50)(H,51,60)(H,53,58,61)	KEZPJKDFSSSWIJ-UHFFFAOYSA-N	648387	US11352350, Compound I-9	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648387	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648387&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			159115245	494493253							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370264	Cn1c2c(CCCCOCCCCNC[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4coc(n4)-c4ccnc(NCC(F)(F)F)c4)c(n3)C(N)=O)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:18.21,wD:15.14,(-14.59,-4.98,;-15.68,-3.89,;-15.36,-2.38,;-14.03,-1.61,;-12.69,-2.38,;-11.36,-1.61,;-10.02,-2.38,;-8.69,-1.61,;-7.36,-2.38,;-6.02,-1.61,;-4.69,-2.38,;-3.36,-1.61,;-2.02,-2.38,;-.69,-1.61,;.65,-2.38,;1.98,-1.61,;3.31,-2.38,;4.65,-1.61,;4.65,-.07,;3.31,.7,;1.98,-.07,;5.98,.7,;7.44,.22,;8.35,1.47,;9.89,1.47,;10.66,.14,;9.89,-1.2,;12.2,.14,;13.11,1.38,;14.57,.91,;14.57,-.63,;13.11,-1.11,;15.66,-1.72,;15.26,-3.21,;16.35,-4.3,;17.84,-3.9,;18.24,-2.41,;19.72,-2.02,;20.81,-3.1,;22.3,-2.71,;23.39,-3.79,;22.7,-1.22,;23.79,-2.31,;17.15,-1.33,;7.44,2.71,;5.98,2.24,;8.21,4.05,;9.75,4.05,;7.44,5.38,;-14.03,-.07,;-15.36,.7,;-16.69,-.07,;-16.69,-1.61,;-17.84,-2.64,;-19.32,-2.24,;-20.41,-3.33,;-21.9,-2.93,;-22.3,-1.45,;-23.79,-1.05,;-21.21,-.36,;-19.72,-.76,;-18.63,.33,;-17.21,-4.05,;-17.98,-5.38,)|	InChI=1S/C43H52F3N11O7/c1-55-37-27(8-6-9-32(37)57(42(55)62)33-14-15-35(58)53-40(33)61)7-2-4-19-63-20-5-3-17-48-22-26-10-12-29(13-11-26)56-23-30(36(54-56)38(47)59)51-39(60)31-24-64-41(52-31)28-16-18-49-34(21-28)50-25-43(44,45)46/h6,8-9,16,18,21,23-24,26,29,33,48H,2-5,7,10-15,17,19-20,22,25H2,1H3,(H2,47,59)(H,49,50)(H,51,60)(H,53,58,61)	LPXVJZOTYPKWAL-UHFFFAOYSA-N	648388	US11352350, Compound I-10	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648388	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648388&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166800747	494493254							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370265	Cn1c2c(CCCOCCNC[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4coc(n4)-c4ccnc(NCC(F)(F)F)c4)c(n3)C(N)=O)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:12.11,wD:15.18,(-12.65,.64,;-13.74,-.45,;-13.42,-1.96,;-12.08,-2.73,;-10.75,-1.96,;-9.42,-2.73,;-8.08,-1.96,;-6.75,-2.73,;-5.42,-1.96,;-4.08,-2.73,;-2.75,-1.96,;-1.41,-2.73,;-.08,-1.96,;-.08,-.42,;1.25,.35,;2.59,-.42,;2.59,-1.96,;1.25,-2.73,;3.92,.35,;5.38,-.12,;6.29,1.12,;7.83,1.12,;8.6,-.21,;7.83,-1.54,;10.14,-.21,;11.05,-1.46,;12.51,-.98,;12.51,.56,;11.05,1.04,;13.84,1.33,;13.84,2.87,;15.18,3.64,;16.51,2.87,;16.51,1.33,;17.84,.56,;19.18,1.33,;20.51,.56,;21.85,1.33,;20.51,-.98,;21.85,-.21,;15.18,.56,;5.38,2.37,;3.92,1.89,;6.15,3.7,;7.69,3.7,;5.38,5.04,;-12.08,-4.27,;-13.42,-5.04,;-14.75,-4.27,;-14.75,-2.73,;-15.9,-1.7,;-17.38,-2.09,;-18.47,-1.01,;-19.96,-1.4,;-20.36,-2.89,;-21.85,-3.29,;-19.27,-3.98,;-17.78,-3.58,;-16.69,-4.67,;-15.27,-.29,;-16.04,1.04,)|	InChI=1S/C40H46F3N11O7/c1-52-34-24(4-2-6-29(34)54(39(52)59)30-11-12-32(55)50-37(30)58)5-3-16-60-17-15-45-19-23-7-9-26(10-8-23)53-20-27(33(51-53)35(44)56)48-36(57)28-21-61-38(49-28)25-13-14-46-31(18-25)47-22-40(41,42)43/h2,4,6,13-14,18,20-21,23,26,30,45H,3,5,7-12,15-17,19,22H2,1H3,(H2,44,56)(H,46,47)(H,48,57)(H,50,55,58)	SFBLANQEOWTKNI-UHFFFAOYSA-N	648389	US11352350, Compound I-11	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648389	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648389&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733270	494493255							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370266	NC(=O)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC(F)(F)F)c1)[C@H]1CC[C@H](CNCCCOCCCc2cccc3n(C4CCC(=O)NC4=O)c(=O)oc23)CC1 |r,wU:31.34,wD:28.30,(8.36,-4.05,;6.82,-4.05,;6.05,-5.38,;6.05,-2.71,;4.59,-2.24,;4.59,-.7,;6.05,-.22,;6.96,-1.47,;8.5,-1.47,;9.27,-.14,;8.5,1.2,;10.81,-.14,;11.71,1.11,;13.18,.63,;13.18,-.91,;11.71,-1.38,;14.51,-1.68,;14.51,-3.22,;15.84,-3.99,;17.18,-3.22,;17.18,-1.68,;18.51,-.91,;19.85,-1.68,;21.18,-.91,;22.51,-1.68,;21.18,.63,;22.51,-.14,;15.84,-.91,;3.25,.07,;3.25,1.61,;1.92,2.38,;.59,1.61,;-.75,2.38,;-2.08,1.61,;-3.41,2.38,;-4.75,1.61,;-6.08,2.38,;-7.42,1.61,;-8.75,2.38,;-10.08,1.61,;-11.42,2.38,;-12.75,1.61,;-12.75,.07,;-14.08,-.7,;-15.42,.07,;-15.42,1.61,;-16.56,2.64,;-18.05,2.24,;-18.45,.76,;-19.94,.36,;-21.03,1.45,;-22.51,1.05,;-20.63,2.93,;-19.14,3.33,;-18.74,4.82,;-15.94,4.05,;-16.71,5.38,;-14.4,3.89,;-14.08,2.38,;.59,.07,;1.92,-.7,)|	InChI=1S/C40H45F3N10O8/c41-40(42,43)22-47-31-18-25(13-15-46-31)38-49-28(21-60-38)36(56)48-27-20-52(51-33(27)35(44)55)26-9-7-23(8-10-26)19-45-14-3-17-59-16-2-5-24-4-1-6-29-34(24)61-39(58)53(29)30-11-12-32(54)50-37(30)57/h1,4,6,13,15,18,20-21,23,26,30,45H,2-3,5,7-12,14,16-17,19,22H2,(H2,44,55)(H,46,47)(H,48,56)(H,50,54,57)	DPWJJOJPVYJPAS-UHFFFAOYSA-N	648390	US11352350, Compound I-12	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 750							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648390	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648390&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733274	494493256							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370267	Cn1c2cc(CCCN3CCO[C@@H](CNC[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)C3)ccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:16.15,wD:12.12,19.22,(18.81,-4.6,;18.42,-3.11,;16.95,-2.64,;15.62,-3.41,;14.28,-2.64,;12.95,-3.41,;11.62,-2.64,;10.28,-3.41,;8.95,-2.64,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,;6.28,-2.64,;4.95,-3.41,;3.61,-2.64,;2.28,-3.41,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,;7.62,-3.41,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,)|	InChI=1S/C45H55F2N11O6/c1-55-37-19-27(8-11-35(37)58(45(55)62)36-12-13-39(59)53-43(36)61)3-2-16-56-17-18-63-32(24-56)23-48-21-28-6-9-31(10-7-28)57-25-33(40(54-57)41(46)47)51-42(60)34-26-64-44(52-34)30-14-15-49-38(20-30)50-22-29-4-5-29/h8,11,14-15,19-20,25-26,28-29,31-32,36,41,48H,2-7,9-10,12-13,16-18,21-24H2,1H3,(H,49,50)(H,51,60)(H,53,59,61)	XRYCGXVWBSOZNI-UHFFFAOYSA-N	648391	US11352350, Compound I-16	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648391	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648391&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733612	494493257							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370268	CN(C[C@@H]1CN(CCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CCO1)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:33.36,3.2,wD:36.43,(3.61,-1.1,;3.61,-2.64,;4.95,-3.41,;6.28,-2.64,;7.62,-3.41,;8.95,-2.64,;10.28,-3.41,;11.62,-2.64,;12.95,-3.41,;14.28,-2.64,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,;18.42,-3.11,;18.81,-4.6,;16.95,-2.64,;15.62,-3.41,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,;2.28,-3.41,;2.28,-4.95,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,)|	InChI=1S/C46H55F2N11O7/c1-55(23-32-24-57(18-19-65-32)17-3-4-27-7-12-35-37(20-27)56(2)46(64)59(35)36-13-14-39(60)53-43(36)62)45(63)29-8-10-31(11-9-29)58-25-33(40(54-58)41(47)48)51-42(61)34-26-66-44(52-34)30-15-16-49-38(21-30)50-22-28-5-6-28/h7,12,15-16,20-21,25-26,28-29,31-32,36,41H,3-6,8-11,13-14,17-19,22-24H2,1-2H3,(H,49,50)(H,51,61)(H,53,60,62)	SUAOOLNWPANBNP-UHFFFAOYSA-N	648392	US11352350, Compound I-17	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648392	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648392&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733760	494493258							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370269	CN(C[C@H]1CN(CCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CCO1)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:33.36,wD:3.2,36.43,(3.61,-1.1,;3.61,-2.64,;4.95,-3.41,;6.28,-2.64,;7.62,-3.41,;8.95,-2.64,;10.28,-3.41,;11.62,-2.64,;12.95,-3.41,;14.28,-2.64,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,;18.42,-3.11,;18.81,-4.6,;16.95,-2.64,;15.62,-3.41,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,;2.28,-3.41,;2.28,-4.95,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,)|	InChI=1S/C46H55F2N11O7/c1-55(23-32-24-57(18-19-65-32)17-3-4-27-7-12-35-37(20-27)56(2)46(64)59(35)36-13-14-39(60)53-43(36)62)45(63)29-8-10-31(11-9-29)58-25-33(40(54-58)41(47)48)51-42(61)34-26-66-44(52-34)30-15-16-49-38(21-30)50-22-28-5-6-28/h7,12,15-16,20-21,25-26,28-29,31-32,36,41H,3-6,8-11,13-14,17-19,22-24H2,1-2H3,(H,49,50)(H,51,61)(H,53,60,62)	SUAOOLNWPANBNP-UHFFFAOYSA-N	648393	US11352350, Compound I-18	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648393	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648393&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			160937247	494493259							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370270	CN(CC1CCN(CCC#Cc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CC1)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:34.37,wD:37.44,(2.95,-3.02,;2.95,-4.56,;4.28,-5.33,;5.61,-4.56,;6.95,-5.33,;8.28,-4.56,;8.28,-3.02,;9.62,-2.25,;10.95,-3.02,;12.28,-2.25,;13.62,-1.48,;14.95,-.71,;14.95,.83,;16.28,1.6,;17.62,.83,;19.08,1.3,;19.48,2.79,;20.97,3.19,;21.37,4.68,;20.28,5.77,;20.68,7.25,;18.79,5.37,;18.39,3.88,;16.9,3.48,;19.99,.06,;21.53,.06,;19.08,-1.19,;19.48,-2.68,;17.62,-.71,;16.28,-1.48,;6.95,-2.25,;5.61,-3.02,;1.61,-5.33,;1.61,-6.87,;.28,-4.56,;-1.05,-5.33,;-2.39,-4.56,;-2.39,-3.02,;-1.05,-2.25,;.28,-3.02,;-3.72,-2.25,;-5.19,-2.73,;-6.09,-1.48,;-7.63,-1.48,;-8.4,-2.82,;-7.63,-4.15,;-9.94,-2.82,;-10.85,-1.57,;-12.31,-2.05,;-12.31,-3.59,;-10.85,-4.06,;-13.4,-4.68,;-13,-6.16,;-14.09,-7.25,;-15.58,-6.85,;-15.98,-5.37,;-17.46,-4.97,;-18.55,-6.06,;-20.04,-5.66,;-21.13,-4.57,;-21.53,-6.06,;-14.89,-4.28,;-5.19,-.24,;-3.72,-.71,;-5.96,1.1,;-7.5,1.1,;-5.19,2.43,)|	InChI=1S/C48H55F2N11O6/c1-57(26-31-17-21-59(22-18-31)20-4-3-5-29-8-13-37-39(23-29)58(2)48(66)61(37)38-14-15-41(62)55-45(38)64)47(65)32-9-11-34(12-10-32)60-27-35(42(56-60)43(49)50)53-44(63)36-28-67-46(54-36)33-16-19-51-40(24-33)52-25-30-6-7-30/h8,13,16,19,23-24,27-28,30-32,34,38,43H,4,6-7,9-12,14-15,17-18,20-22,25-26H2,1-2H3,(H,51,52)(H,53,63)(H,55,62,64)	GJHUQOSRXHILOG-UHFFFAOYSA-N	648394	US11352350, Compound I-27	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648394	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648394&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			158273329	494493260							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370271	CN(CCCOCCCc1cccc2n(C3CCC(=O)NC3=O)c(=O)n(C)c12)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:30.32,wD:33.39,(2.02,-.07,;2.02,-1.61,;3.36,-2.38,;4.69,-1.61,;6.02,-2.38,;7.36,-1.61,;8.69,-2.38,;10.02,-1.61,;11.36,-2.38,;12.69,-1.61,;12.69,-.07,;14.03,.7,;15.36,-.07,;15.36,-1.61,;16.5,-2.64,;17.99,-2.24,;19.08,-3.33,;20.57,-2.93,;20.97,-1.45,;22.45,-1.05,;19.88,-.36,;18.39,-.76,;17.3,.33,;15.88,-4.05,;16.65,-5.38,;14.35,-3.89,;13.26,-4.98,;14.03,-2.38,;.69,-2.38,;.69,-3.92,;-.65,-1.61,;-1.98,-2.38,;-3.31,-1.61,;-3.31,-.07,;-1.98,.7,;-.65,-.07,;-4.65,.7,;-6.11,.22,;-7.02,1.47,;-8.56,1.47,;-9.33,.14,;-8.56,-1.2,;-10.87,.14,;-11.77,1.38,;-13.24,.91,;-13.24,-.63,;-11.77,-1.11,;-14.33,-1.72,;-13.93,-3.21,;-15.02,-4.3,;-16.5,-3.9,;-16.9,-2.41,;-18.39,-2.02,;-19.48,-3.1,;-20.97,-2.71,;-22.05,-1.62,;-22.45,-3.1,;-15.81,-1.33,;-6.11,2.71,;-4.65,2.24,;-6.88,4.05,;-8.42,4.05,;-6.11,5.38,)|	InChI=1S/C44H52F2N10O7/c1-53(19-5-21-62-20-4-7-27-6-3-8-33-38(27)54(2)44(61)56(33)34-15-16-36(57)51-41(34)59)43(60)28-11-13-30(14-12-28)55-24-31(37(52-55)39(45)46)49-40(58)32-25-63-42(50-32)29-17-18-47-35(22-29)48-23-26-9-10-26/h3,6,8,17-18,22,24-26,28,30,34,39H,4-5,7,9-16,19-21,23H2,1-2H3,(H,47,48)(H,49,58)(H,51,57,59)	HFLBPMBNSWWPPL-UHFFFAOYSA-N	648395	US11352350, Compound I-30::US11352350, Compound I-28	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648395	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648395&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			163610427	494493261							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370272	CN(CCCOCCCc1cccc2n(C3CCC(=O)NC3=O)c(=O)n(C)c12)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC(F)(F)F)c2)c(n1)C(N)=O |r,wU:30.32,wD:33.39,(2.02,-.07,;2.02,-1.61,;3.36,-2.38,;4.69,-1.61,;6.02,-2.38,;7.36,-1.61,;8.69,-2.38,;10.02,-1.61,;11.36,-2.38,;12.69,-1.61,;12.69,-.07,;14.03,.7,;15.36,-.07,;15.36,-1.61,;16.5,-2.64,;17.99,-2.24,;19.08,-3.33,;20.57,-2.93,;20.97,-1.45,;22.45,-1.05,;19.88,-.36,;18.39,-.76,;17.3,.33,;15.88,-4.05,;16.65,-5.38,;14.35,-3.89,;13.26,-4.98,;14.03,-2.38,;.69,-2.38,;.69,-3.92,;-.65,-1.61,;-1.98,-2.38,;-3.31,-1.61,;-3.31,-.07,;-1.98,.7,;-.65,-.07,;-4.65,.7,;-6.11,.22,;-7.02,1.47,;-8.56,1.47,;-9.33,.14,;-8.56,-1.2,;-10.87,.14,;-11.77,1.38,;-13.24,.91,;-13.24,-.63,;-11.77,-1.11,;-14.33,-1.72,;-13.93,-3.21,;-15.02,-4.3,;-16.5,-3.9,;-16.9,-2.41,;-18.39,-2.02,;-19.48,-3.1,;-20.97,-2.71,;-22.05,-3.79,;-21.36,-1.22,;-22.45,-2.31,;-15.81,-1.33,;-6.11,2.71,;-4.65,2.24,;-6.88,4.05,;-8.42,4.05,;-6.11,5.38,)|	InChI=1S/C42H48F3N11O8/c1-53(17-5-19-63-18-4-7-24-6-3-8-30-35(24)54(2)41(62)56(30)31-13-14-33(57)51-38(31)60)40(61)25-9-11-27(12-10-25)55-21-28(34(52-55)36(46)58)49-37(59)29-22-64-39(50-29)26-15-16-47-32(20-26)48-23-42(43,44)45/h3,6,8,15-16,20-22,25,27,31H,4-5,7,9-14,17-19,23H2,1-2H3,(H2,46,58)(H,47,48)(H,49,59)(H,51,57,60)	DIJBZQJJHLDFOO-UHFFFAOYSA-N	648396	US11352350, Compound I-29	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 750							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648396	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648396&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			146598776	494493262							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370273	CN(CCCOCCCc1cccc2n(C3CCC(=O)NC3=O)c(=O)n(C)c12)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:30.32,wD:33.39,(2.02,-.07,;2.02,-1.61,;3.36,-2.38,;4.69,-1.61,;6.02,-2.38,;7.36,-1.61,;8.69,-2.38,;10.02,-1.61,;11.36,-2.38,;12.69,-1.61,;12.69,-.07,;14.03,.7,;15.36,-.07,;15.36,-1.61,;16.5,-2.64,;17.99,-2.24,;19.08,-3.33,;20.57,-2.93,;20.97,-1.45,;22.45,-1.05,;19.88,-.36,;18.39,-.76,;17.3,.33,;15.88,-4.05,;16.65,-5.38,;14.35,-3.89,;13.26,-4.98,;14.03,-2.38,;.69,-2.38,;.69,-3.92,;-.65,-1.61,;-1.98,-2.38,;-3.31,-1.61,;-3.31,-.07,;-1.98,.7,;-.65,-.07,;-4.65,.7,;-6.11,.22,;-7.02,1.47,;-8.56,1.47,;-9.33,.14,;-8.56,-1.2,;-10.87,.14,;-11.77,1.38,;-13.24,.91,;-13.24,-.63,;-11.77,-1.11,;-14.33,-1.72,;-13.93,-3.21,;-15.02,-4.3,;-16.5,-3.9,;-16.9,-2.41,;-18.39,-2.02,;-19.48,-3.1,;-20.97,-2.71,;-22.05,-1.62,;-22.45,-3.1,;-15.81,-1.33,;-6.11,2.71,;-4.65,2.24,;-6.88,4.05,;-8.42,4.05,;-6.11,5.38,)|	InChI=1S/C44H52F2N10O7/c1-53(19-5-21-62-20-4-7-27-6-3-8-33-38(27)54(2)44(61)56(33)34-15-16-36(57)51-41(34)59)43(60)28-11-13-30(14-12-28)55-24-31(37(52-55)39(45)46)49-40(58)32-25-63-42(50-32)29-17-18-47-35(22-29)48-23-26-9-10-26/h3,6,8,17-18,22,24-26,28,30,34,39H,4-5,7,9-16,19-21,23H2,1-2H3,(H,47,48)(H,49,58)(H,51,57,59)	HFLBPMBNSWWPPL-UHFFFAOYSA-N	648395	US11352350, Compound I-30::US11352350, Compound I-28	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648395	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648395&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			163610427	494493261							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370274	CN(CCCOCCCc1cccc2n(C3CCC(=O)NC3=O)c(=O)n(C)c12)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(C)=C |r,wU:30.32,wD:33.39,(2.02,-.07,;2.02,-1.61,;3.36,-2.38,;4.69,-1.61,;6.02,-2.38,;7.36,-1.61,;8.69,-2.38,;10.02,-1.61,;11.36,-2.38,;12.69,-1.61,;12.69,-.07,;14.03,.7,;15.36,-.07,;15.36,-1.61,;16.5,-2.64,;17.99,-2.24,;19.08,-3.33,;20.57,-2.93,;20.97,-1.45,;22.45,-1.05,;19.88,-.36,;18.39,-.76,;17.3,.33,;15.88,-4.05,;16.65,-5.38,;14.35,-3.89,;13.26,-4.98,;14.03,-2.38,;.69,-2.38,;.69,-3.92,;-.65,-1.61,;-1.98,-2.38,;-3.31,-1.61,;-3.31,-.07,;-1.98,.7,;-.65,-.07,;-4.65,.7,;-6.11,.22,;-7.02,1.47,;-8.56,1.47,;-9.33,.14,;-8.56,-1.2,;-10.87,.14,;-11.77,1.38,;-13.24,.91,;-13.24,-.63,;-11.77,-1.11,;-14.33,-1.72,;-13.93,-3.21,;-15.02,-4.3,;-16.5,-3.9,;-16.9,-2.41,;-18.39,-2.02,;-19.48,-3.1,;-20.97,-2.71,;-22.05,-1.62,;-22.45,-3.1,;-15.81,-1.33,;-6.11,2.71,;-4.65,2.24,;-6.88,4.05,;-6.11,5.38,;-8.42,4.05,)|	InChI=1S/C46H56N10O7/c1-28(2)40-34(49-42(58)35-27-63-44(50-35)32-19-20-47-38(24-32)48-25-29-11-12-29)26-55(52-40)33-15-13-31(14-16-33)45(60)53(3)21-7-23-62-22-6-9-30-8-5-10-36-41(30)54(4)46(61)56(36)37-17-18-39(57)51-43(37)59/h5,8,10,19-20,24,26-27,29,31,33,37H,1,6-7,9,11-18,21-23,25H2,2-4H3,(H,47,48)(H,49,58)(H,51,57,59)	BKMZNQVGMKSBSV-UHFFFAOYSA-N	648398	US11352350, Compound I-31	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648398	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648398&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			163455989	494493263							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370275	CN(CCOCCOCCCc1cccc2n(C3CCC(=O)NC3=O)c(=O)n(C)c12)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:32.34,wD:35.41,(.69,-.07,;.69,-1.61,;2.02,-2.38,;3.36,-1.61,;4.69,-2.38,;6.02,-1.61,;7.36,-2.38,;8.69,-1.61,;10.02,-2.38,;11.36,-1.61,;12.69,-2.38,;14.03,-1.61,;14.03,-.07,;15.36,.7,;16.69,-.07,;16.69,-1.61,;17.84,-2.64,;19.32,-2.24,;20.41,-3.33,;21.9,-2.93,;22.3,-1.45,;23.79,-1.05,;21.21,-.36,;19.72,-.76,;18.63,.33,;17.21,-4.05,;17.98,-5.38,;15.68,-3.89,;14.59,-4.98,;15.36,-2.38,;-.65,-2.38,;-.65,-3.92,;-1.98,-1.61,;-3.31,-2.38,;-4.65,-1.61,;-4.65,-.07,;-3.31,.7,;-1.98,-.07,;-5.98,.7,;-7.44,.22,;-8.35,1.47,;-9.89,1.47,;-10.66,.14,;-9.89,-1.2,;-12.2,.14,;-13.11,1.38,;-14.57,.91,;-14.57,-.63,;-13.11,-1.11,;-15.66,-1.72,;-15.26,-3.21,;-16.35,-4.3,;-17.84,-3.9,;-18.24,-2.41,;-19.72,-2.02,;-20.81,-3.1,;-22.3,-2.71,;-23.39,-1.62,;-23.79,-3.1,;-17.15,-1.33,;-7.44,2.71,;-5.98,2.24,;-8.21,4.05,;-9.75,4.05,;-7.44,5.38,)|	InChI=1S/C45H54F2N10O8/c1-54(18-20-64-22-21-63-19-4-6-28-5-3-7-34-39(28)55(2)45(62)57(34)35-14-15-37(58)52-42(35)60)44(61)29-10-12-31(13-11-29)56-25-32(38(53-56)40(46)47)50-41(59)33-26-65-43(51-33)30-16-17-48-36(23-30)49-24-27-8-9-27/h3,5,7,16-17,23,25-27,29,31,35,40H,4,6,8-15,18-22,24H2,1-2H3,(H,48,49)(H,50,59)(H,52,58,60)	BQRJVHKUGFHSDB-UHFFFAOYSA-N	648399	US11352350, Compound I-32	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648399	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648399&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733711	494493264							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370276	CN(C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(C)(C)O)C[C@@H]1CN(CCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CCO1 |r,wU:3.2,38.42,wD:6.9,(3.61,-1.1,;3.61,-2.64,;2.28,-3.41,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,;-6.06,4.35,;4.95,-3.41,;6.28,-2.64,;7.62,-3.41,;8.95,-2.64,;10.28,-3.41,;11.62,-2.64,;12.95,-3.41,;14.28,-2.64,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,;18.42,-3.11,;18.81,-4.6,;16.95,-2.64,;15.62,-3.41,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,)|	InChI=1S/C48H63N11O7/c1-48(2,64)43-36(51-44(61)37-29-66-46(52-37)33-17-18-49-41(23-33)50-24-31-7-8-31)28-58(54-43)34-12-9-32(10-13-34)25-55(3)26-35-27-57(20-21-65-35)19-5-6-30-11-14-38-40(22-30)56(4)47(63)59(38)39-15-16-42(60)53-45(39)62/h11,14,17-18,22-23,28-29,31-32,34-35,39,64H,5-10,12-13,15-16,19-21,24-27H2,1-4H3,(H,49,50)(H,51,61)(H,53,60,62)	WGYOYYGDAGDYQS-UHFFFAOYSA-N	648400	US11352350, Compound I-33	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 750							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648400	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648400&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			164061094	494493265							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370277	CN(C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F)C[C@H]1CN(CCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CCO1 |r,wU:3.2,wD:37.41,6.9,(3.61,-1.1,;3.61,-2.64,;2.28,-3.41,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,;4.95,-3.41,;6.28,-2.64,;7.62,-3.41,;8.95,-2.64,;10.28,-3.41,;11.62,-2.64,;12.95,-3.41,;14.28,-2.64,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,;18.42,-3.11,;18.81,-4.6,;16.95,-2.64,;15.62,-3.41,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,)|	InChI=1S/C46H57F2N11O6/c1-55(24-33-25-57(18-19-64-33)17-3-4-28-9-12-36-38(20-28)56(2)46(63)59(36)37-13-14-40(60)53-44(37)62)23-30-7-10-32(11-8-30)58-26-34(41(54-58)42(47)48)51-43(61)35-27-65-45(52-35)31-15-16-49-39(21-31)50-22-29-5-6-29/h9,12,15-16,20-21,26-27,29-30,32-33,37,42H,3-8,10-11,13-14,17-19,22-25H2,1-2H3,(H,49,50)(H,51,61)(H,53,60,62)	ZHYPELBSLFFEAM-UHFFFAOYSA-N	648401	US11352350, Compound I-34	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648401	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648401&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733637	494493266							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370278	Cn1c2cc(CCCN3CCO[C@H](CNC[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)C3)ccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:16.15,12.12,wD:19.22,(18.81,-4.6,;18.42,-3.11,;16.95,-2.64,;15.62,-3.41,;14.28,-2.64,;12.95,-3.41,;11.62,-2.64,;10.28,-3.41,;8.95,-2.64,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,;6.28,-2.64,;4.95,-3.41,;3.61,-2.64,;2.28,-3.41,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,;7.62,-3.41,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,)|	InChI=1S/C45H55F2N11O6/c1-55-37-19-27(8-11-35(37)58(45(55)62)36-12-13-39(59)53-43(36)61)3-2-16-56-17-18-63-32(24-56)23-48-21-28-6-9-31(10-7-28)57-25-33(40(54-57)41(46)47)51-42(60)34-26-64-44(52-34)30-14-15-49-38(20-30)50-22-29-4-5-29/h8,11,14-15,19-20,25-26,28-29,31-32,36,41,48H,2-7,9-10,12-13,16-18,21-24H2,1H3,(H,49,50)(H,51,60)(H,53,59,61)	XRYCGXVWBSOZNI-UHFFFAOYSA-N	648402	US11352350, Compound I-35	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648402	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648402&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			164104975	494493267							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370279	CN(C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F)C[C@@H]1CN(CCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CCO1 |r,wU:3.2,37.41,wD:6.9,(3.61,-1.1,;3.61,-2.64,;2.28,-3.41,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,;4.95,-3.41,;6.28,-2.64,;7.62,-3.41,;8.95,-2.64,;10.28,-3.41,;11.62,-2.64,;12.95,-3.41,;14.28,-2.64,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,;18.42,-3.11,;18.81,-4.6,;16.95,-2.64,;15.62,-3.41,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,)|	InChI=1S/C46H57F2N11O6/c1-55(24-33-25-57(18-19-64-33)17-3-4-28-9-12-36-38(20-28)56(2)46(63)59(36)37-13-14-40(60)53-44(37)62)23-30-7-10-32(11-8-30)58-26-34(41(54-58)42(47)48)51-43(61)35-27-65-45(52-35)31-15-16-49-39(21-31)50-22-29-5-6-29/h9,12,15-16,20-21,26-27,29-30,32-33,37,42H,3-8,10-11,13-14,17-19,22-25H2,1-2H3,(H,49,50)(H,51,61)(H,53,60,62)	ZHYPELBSLFFEAM-UHFFFAOYSA-N	648403	US11352350, Compound I-36	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648403	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648403&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			164155023	494493268							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370280	Cn1c2c(CCCN3CCO[C@H](CNC[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)C3)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:15.14,wD:18.21,11.11,(16.98,.25,;16.58,1.73,;15.11,2.21,;13.78,1.44,;13.78,-.1,;12.45,-.87,;12.45,-2.41,;11.11,-3.18,;11.11,-4.72,;9.78,-5.49,;8.44,-4.72,;8.44,-3.18,;7.11,-2.41,;5.78,-3.18,;4.44,-2.41,;3.11,-3.18,;3.11,-4.72,;1.78,-5.49,;.44,-4.72,;.44,-3.18,;1.78,-2.41,;-.89,-5.49,;-2.36,-5.02,;-3.26,-6.26,;-4.8,-6.26,;-5.57,-4.93,;-4.8,-3.59,;-7.11,-4.93,;-8.02,-3.68,;-9.48,-4.16,;-9.48,-5.7,;-8.02,-6.17,;-10.81,-6.47,;-10.81,-8.01,;-12.15,-8.78,;-13.48,-8.01,;-13.48,-6.47,;-14.82,-5.7,;-16.15,-6.47,;-17.48,-5.7,;-18.25,-4.36,;-19.02,-5.7,;-12.15,-5.7,;-2.36,-7.51,;-.89,-7.03,;-3.13,-8.84,;-4.67,-8.84,;-2.36,-10.17,;9.78,-2.41,;12.45,2.21,;12.45,3.75,;13.78,4.52,;15.11,3.75,;16.58,4.22,;16.98,5.71,;18.46,6.11,;18.86,7.6,;17.77,8.69,;18.17,10.17,;16.29,8.29,;15.89,6.8,;14.4,6.4,;17.48,2.98,;19.02,2.98,)|	InChI=1S/C45H55F2N11O6/c1-55-40-29(4-2-6-35(40)58(45(55)62)36-13-14-38(59)53-43(36)61)5-3-17-56-18-19-63-32(24-56)23-48-21-27-9-11-31(12-10-27)57-25-33(39(54-57)41(46)47)51-42(60)34-26-64-44(52-34)30-15-16-49-37(20-30)50-22-28-7-8-28/h2,4,6,15-16,20,25-28,31-32,36,41,48H,3,5,7-14,17-19,21-24H2,1H3,(H,49,50)(H,51,60)(H,53,59,61)	WHWXMWYOTGWZBZ-UHFFFAOYSA-N	648404	US11352350, Compound I-37	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648404	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648404&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733771	494493269							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370281	Cn1c2c(CCCN3CCO[C@@H](CNC[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)C3)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:15.14,11.11,wD:18.21,(16.98,.25,;16.58,1.73,;15.11,2.21,;13.78,1.44,;13.78,-.1,;12.45,-.87,;12.45,-2.41,;11.11,-3.18,;11.11,-4.72,;9.78,-5.49,;8.44,-4.72,;8.44,-3.18,;7.11,-2.41,;5.78,-3.18,;4.44,-2.41,;3.11,-3.18,;3.11,-4.72,;1.78,-5.49,;.44,-4.72,;.44,-3.18,;1.78,-2.41,;-.89,-5.49,;-2.36,-5.02,;-3.26,-6.26,;-4.8,-6.26,;-5.57,-4.93,;-4.8,-3.59,;-7.11,-4.93,;-8.02,-3.68,;-9.48,-4.16,;-9.48,-5.7,;-8.02,-6.17,;-10.81,-6.47,;-10.81,-8.01,;-12.15,-8.78,;-13.48,-8.01,;-13.48,-6.47,;-14.82,-5.7,;-16.15,-6.47,;-17.48,-5.7,;-18.25,-4.36,;-19.02,-5.7,;-12.15,-5.7,;-2.36,-7.51,;-.89,-7.03,;-3.13,-8.84,;-4.67,-8.84,;-2.36,-10.17,;9.78,-2.41,;12.45,2.21,;12.45,3.75,;13.78,4.52,;15.11,3.75,;16.58,4.22,;16.98,5.71,;18.46,6.11,;18.86,7.6,;17.77,8.69,;18.17,10.17,;16.29,8.29,;15.89,6.8,;14.4,6.4,;17.48,2.98,;19.02,2.98,)|	InChI=1S/C45H55F2N11O6/c1-55-40-29(4-2-6-35(40)58(45(55)62)36-13-14-38(59)53-43(36)61)5-3-17-56-18-19-63-32(24-56)23-48-21-27-9-11-31(12-10-27)57-25-33(39(54-57)41(46)47)51-42(60)34-26-64-44(52-34)30-15-16-49-37(20-30)50-22-28-7-8-28/h2,4,6,15-16,20,25-28,31-32,36,41,48H,3,5,7-14,17-19,21-24H2,1H3,(H,49,50)(H,51,60)(H,53,59,61)	WHWXMWYOTGWZBZ-UHFFFAOYSA-N	648405	US11352350, Compound I-38	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648405	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648405&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			164062186	494493270							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370282	FC(F)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC2CC2)c1)[C@H]1CC[C@H](CNC[C@H]2CN(CC#Cc3cccc(c3)[C@H]3CN(C4CCC(=O)NC4=O)C(=O)O3)CCO2)CC1 |r,wU:30.34,46.50,wD:34.37,27.30,(-9.64,3.53,;-8.1,3.53,;-7.33,4.86,;-7.33,2.2,;-5.87,1.72,;-5.87,.18,;-7.33,-.3,;-8.24,.95,;-9.78,.95,;-10.55,-.38,;-9.78,-1.72,;-12.09,-.38,;-12.99,-1.63,;-14.46,-1.15,;-14.46,.39,;-12.99,.86,;-15.79,1.16,;-15.79,2.7,;-17.13,3.47,;-18.46,2.7,;-18.46,1.16,;-19.79,.39,;-21.13,1.16,;-22.46,.39,;-24,.39,;-23.23,-.95,;-17.13,.39,;-4.53,-.59,;-4.53,-2.13,;-3.2,-2.9,;-1.87,-2.13,;-.53,-2.9,;.8,-2.13,;2.13,-2.9,;3.47,-2.13,;4.8,-2.9,;6.13,-2.13,;7.47,-2.9,;8.8,-2.13,;10.14,-1.36,;11.47,-.59,;11.47,.95,;12.8,1.72,;14.14,.95,;14.14,-.59,;12.8,-1.36,;15.47,-1.36,;16.93,-.88,;17.84,-2.13,;19.38,-2.13,;20.15,-.8,;21.69,-.8,;22.46,-2.13,;24,-2.13,;21.69,-3.46,;20.15,-3.46,;19.38,-4.8,;16.93,-3.38,;17.33,-4.86,;15.47,-2.9,;6.13,-.59,;4.8,.18,;3.47,-.59,;-1.87,-.59,;-3.2,.18,)|	InChI=1S/C46H52F2N10O7/c47-42(48)41-35(52-43(60)36-27-64-45(53-36)32-14-15-50-39(20-32)51-22-30-6-7-30)25-58(55-41)33-10-8-29(9-11-33)21-49-23-34-24-56(17-18-63-34)16-2-4-28-3-1-5-31(19-28)38-26-57(46(62)65-38)37-12-13-40(59)54-44(37)61/h1,3,5,14-15,19-20,25,27,29-30,33-34,37-38,42,49H,6-13,16-18,21-24,26H2,(H,50,51)(H,52,60)(H,54,59,61)	ZQXFECYNFBKJPH-UHFFFAOYSA-N	648406	US11352350, Compound I-39	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648406	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648406&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733854	494493271							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370283	FC(F)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC2CC2)c1)[C@H]1CC[C@H](CNC[C@H]2CN(CC#Cc3ccc(cc3)[C@H]3CN(C4CCC(=O)NC4=O)C(=O)O3)CCO2)CC1 |r,wU:30.34,wD:34.37,27.30,46.50,(-9.64,2.37,;-8.1,2.37,;-7.33,3.7,;-7.33,1.03,;-5.87,.56,;-5.87,-.98,;-7.33,-1.46,;-8.24,-.21,;-9.78,-.21,;-10.55,-1.55,;-9.78,-2.88,;-12.09,-1.55,;-12.99,-2.79,;-14.46,-2.32,;-14.46,-.78,;-12.99,-.3,;-15.79,-.01,;-15.79,1.53,;-17.13,2.3,;-18.46,1.53,;-18.46,-.01,;-19.79,-.78,;-21.13,-.01,;-22.46,-.78,;-24,-.78,;-23.23,-2.11,;-17.13,-.78,;-4.53,-1.75,;-4.53,-3.29,;-3.2,-4.06,;-1.87,-3.29,;-.53,-4.06,;.8,-3.29,;2.13,-4.06,;3.47,-3.29,;4.8,-4.06,;6.13,-3.29,;7.47,-4.06,;8.8,-3.29,;10.14,-2.52,;11.47,-1.75,;12.8,-2.52,;14.14,-1.75,;14.14,-.21,;12.8,.56,;11.47,-.21,;15.47,.56,;16.93,.08,;17.84,1.33,;19.38,1.33,;20.15,2.66,;21.69,2.66,;22.46,1.33,;24,1.33,;21.69,-.01,;20.15,-.01,;19.38,-1.34,;16.93,2.57,;17.33,4.06,;15.47,2.1,;6.13,-1.75,;4.8,-.98,;3.47,-1.75,;-1.87,-1.75,;-3.2,-.98,)|	InChI=1S/C46H52F2N10O7/c47-42(48)41-35(52-43(60)36-27-64-45(53-36)32-15-16-50-39(20-32)51-22-30-3-4-30)25-58(55-41)33-11-7-29(8-12-33)21-49-23-34-24-56(18-19-63-34)17-1-2-28-5-9-31(10-6-28)38-26-57(46(62)65-38)37-13-14-40(59)54-44(37)61/h5-6,9-10,15-16,20,25,27,29-30,33-34,37-38,42,49H,3-4,7-8,11-14,17-19,21-24,26H2,(H,50,51)(H,52,60)(H,54,59,61)	ZJKRNNIIEMHRJX-UHFFFAOYSA-N	648407	US11352350, Compound I-40	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648407	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648407&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733808	494493272							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370284	Cn1c2cc(CCOCCN3CCO[C@@H](CNC[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5cnn6ccc(nc56)N5CCNCC5)c(n4)C(F)F)C3)ccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:14.14,21.24,wD:18.17,(16.11,2.7,;15.71,1.21,;14.25,.73,;12.91,1.5,;11.58,.73,;10.25,1.5,;8.91,.73,;7.58,1.5,;6.25,.73,;4.91,1.5,;3.58,.73,;3.58,-.81,;2.25,-1.58,;.91,-.81,;.91,.73,;-.42,1.5,;-1.76,.73,;-3.09,1.5,;-4.42,.73,;-5.76,1.5,;-7.09,.73,;-7.09,-.81,;-5.76,-1.58,;-4.42,-.81,;-8.42,-1.58,;-9.89,-1.1,;-10.79,-2.35,;-12.33,-2.35,;-13.1,-1.01,;-12.33,.32,;-14.64,-1.01,;-15.55,-2.26,;-17.01,-1.78,;-17.01,-.24,;-18.16,.79,;-17.84,2.29,;-16.37,2.77,;-15.23,1.74,;-15.55,.23,;-15.97,4.26,;-14.49,4.66,;-14.09,6.14,;-15.18,7.23,;-16.67,6.83,;-17.06,5.35,;-9.89,-3.59,;-8.42,-3.12,;-10.66,-4.93,;-12.2,-4.93,;-9.89,-6.26,;2.25,1.5,;11.58,-.81,;12.91,-1.58,;14.25,-.81,;15.71,-1.28,;16.11,-2.77,;17.6,-3.17,;18,-4.66,;16.91,-5.74,;17.31,-7.23,;15.42,-5.35,;15.02,-3.86,;13.54,-3.46,;16.62,-.04,;18.16,-.04,)|	InChI=1S/C44H57F2N13O6/c1-54-36-22-28(4-7-34(36)59(44(54)63)35-8-9-38(60)52-43(35)62)11-19-64-20-17-55-18-21-65-31(26-55)24-48-23-29-2-5-30(6-3-29)58-27-33(39(53-58)40(45)46)50-42(61)32-25-49-57-14-10-37(51-41(32)57)56-15-12-47-13-16-56/h4,7,10,14,22,25,27,29-31,35,40,47-48H,2-3,5-6,8-9,11-13,15-21,23-24,26H2,1H3,(H,50,61)(H,52,60,62)	WMMYDLRQSDRITM-UHFFFAOYSA-N	648408	US11352350, Compound I-41	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648408	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648408&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733609	494493273							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370285	Cn1c2cc(CCCCOCCCCNC[C@H]3CC[C@@H](CC3)n3cc(NC(=O)c4cnn5ccc(nc45)N4CCNCC4)c(n3)C(F)F)ccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:16.15,wD:19.22,(16.11,-2.7,;15.71,-1.21,;14.25,-.73,;12.91,-1.5,;11.58,-.73,;10.25,-1.5,;8.91,-.73,;7.58,-1.5,;6.25,-.73,;4.91,-1.5,;3.58,-.73,;2.25,-1.5,;.91,-.73,;-.42,-1.5,;-1.76,-.73,;-3.09,-1.5,;-4.42,-.73,;-5.76,-1.5,;-7.09,-.73,;-7.09,.81,;-5.76,1.58,;-4.42,.81,;-8.42,1.58,;-9.89,1.1,;-10.79,2.35,;-12.33,2.35,;-13.1,1.01,;-12.33,-.32,;-14.64,1.01,;-15.55,2.26,;-17.01,1.78,;-17.01,.24,;-18.16,-.79,;-17.84,-2.29,;-16.37,-2.77,;-15.23,-1.74,;-15.55,-.23,;-15.97,-4.26,;-14.49,-4.66,;-14.09,-6.14,;-15.18,-7.23,;-16.67,-6.83,;-17.06,-5.35,;-9.89,3.59,;-8.42,3.12,;-10.66,4.93,;-12.2,4.93,;-9.89,6.26,;11.58,.81,;12.91,1.58,;14.25,.81,;15.71,1.28,;16.11,2.77,;17.6,3.17,;18,4.66,;16.91,5.74,;17.31,7.23,;15.42,5.35,;15.02,3.86,;13.54,3.46,;16.62,.04,;18.16,.04,)|	InChI=1S/C43H56F2N12O5/c1-53-35-24-28(9-12-33(35)57(43(53)61)34-13-14-37(58)51-42(34)60)6-2-4-22-62-23-5-3-16-47-25-29-7-10-30(11-8-29)56-27-32(38(52-56)39(44)45)49-41(59)31-26-48-55-19-15-36(50-40(31)55)54-20-17-46-18-21-54/h9,12,15,19,24,26-27,29-30,34,39,46-47H,2-8,10-11,13-14,16-18,20-23,25H2,1H3,(H,49,59)(H,51,58,60)	DMIBBFHVKKYGAW-UHFFFAOYSA-N	648409	US11352350, Compound I-42	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648409	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648409&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733308	494493274							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370286	CN(CCOCCOCCCc1ccc2n(C3CCC(=O)NC3=O)c(=O)oc2c1)C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:30.32,wD:33.39,(2.28,-1.1,;2.28,-2.64,;3.61,-3.41,;4.95,-2.64,;6.28,-3.41,;7.62,-2.64,;8.95,-3.41,;10.28,-2.64,;11.62,-3.41,;12.95,-2.64,;14.28,-3.41,;15.62,-2.64,;15.62,-1.1,;16.95,-.33,;18.28,-1.1,;19.75,-.62,;20.15,.87,;21.64,1.26,;22.03,2.75,;20.94,3.84,;21.34,5.33,;19.46,3.44,;19.06,1.95,;17.57,1.56,;20.65,-1.87,;22.19,-1.87,;19.75,-3.11,;18.28,-2.64,;16.95,-3.41,;.95,-3.41,;-.39,-2.64,;-1.72,-3.41,;-3.05,-2.64,;-3.05,-1.1,;-1.72,-.33,;-.39,-1.1,;-4.39,-.33,;-5.85,-.8,;-6.76,.44,;-8.3,.44,;-9.07,-.89,;-8.3,-2.23,;-10.61,-.89,;-11.51,.35,;-12.98,-.12,;-12.98,-1.66,;-11.51,-2.14,;-14.07,-2.75,;-13.67,-4.24,;-14.76,-5.33,;-16.24,-4.93,;-16.64,-3.44,;-18.13,-3.04,;-19.22,-4.13,;-20.71,-3.73,;-21.8,-2.64,;-22.19,-4.13,;-15.55,-2.35,;-5.85,1.69,;-4.39,1.21,;-6.62,3.02,;-8.16,3.02,;-5.85,4.35,)|	InChI=1S/C44H53F2N9O8/c1-53(16-18-61-20-19-60-17-2-3-27-8-11-34-36(21-27)63-44(59)55(34)35-12-13-38(56)51-42(35)58)24-29-6-9-31(10-7-29)54-25-32(39(52-54)40(45)46)49-41(57)33-26-62-43(50-33)30-14-15-47-37(22-30)48-23-28-4-5-28/h8,11,14-15,21-22,25-26,28-29,31,35,40H,2-7,9-10,12-13,16-20,23-24H2,1H3,(H,47,48)(H,49,57)(H,51,56,58)	LPCPJUYIKKZIRI-UHFFFAOYSA-N	648410	US11352350, Compound I-43	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648410	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648410&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733287	494493275							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370287	CN([C@H]1C[C@@H](C1)OCCN1CCN(Cc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CC1)C(=O)[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:37.41,2.1,wD:40.48,4.6,(2.17,-2.19,;2.17,-.65,;3.5,.12,;3.9,1.61,;5.39,1.21,;4.99,-.27,;6.72,1.98,;8.05,1.21,;9.39,1.98,;10.72,1.21,;12.06,1.98,;13.39,1.21,;13.39,-.33,;14.72,-1.1,;16.06,-.33,;16.06,1.21,;17.39,1.98,;18.72,1.21,;20.19,1.69,;20.59,3.18,;22.07,3.58,;22.47,5.06,;21.38,6.15,;21.78,7.64,;19.9,5.75,;19.5,4.27,;18.01,3.87,;21.09,.44,;22.63,.44,;20.19,-.8,;20.59,-2.29,;18.72,-.33,;17.39,-1.1,;12.06,-1.1,;10.72,-.33,;.83,.12,;.83,1.66,;-.5,-.65,;-.5,-2.19,;-1.83,-2.96,;-3.17,-2.19,;-3.17,-.65,;-1.83,.12,;-4.5,-2.96,;-5.97,-2.48,;-6.87,-3.73,;-8.41,-3.73,;-9.18,-2.39,;-8.41,-1.06,;-10.72,-2.39,;-11.63,-1.15,;-13.09,-1.62,;-13.09,-3.16,;-11.63,-3.64,;-14.42,-3.93,;-14.42,-5.47,;-15.76,-6.24,;-17.09,-5.47,;-17.09,-3.93,;-18.43,-3.16,;-19.76,-3.93,;-21.09,-3.16,;-21.86,-1.83,;-22.63,-3.16,;-15.76,-3.16,;-5.97,-4.97,;-4.5,-4.5,;-6.74,-6.31,;-8.28,-6.31,;-5.97,-7.64,)|	InChI=1S/C49H60F2N12O7/c1-58(34-23-35(24-34)69-20-19-60-15-17-61(18-16-60)26-30-5-10-38-40(21-30)59(2)49(68)63(38)39-11-12-42(64)56-46(39)66)48(67)31-6-8-33(9-7-31)62-27-36(43(57-62)44(50)51)54-45(65)37-28-70-47(55-37)32-13-14-52-41(22-32)53-25-29-3-4-29/h5,10,13-14,21-22,27-29,31,33-35,39,44H,3-4,6-9,11-12,15-20,23-26H2,1-2H3,(H,52,53)(H,54,65)(H,56,64,66)	JMGAZFOGOXANME-UHFFFAOYSA-N	648411	US11352350, Compound I-45	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648411	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648411&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733811	494493276							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370288	CN(CCCOCCCc1ccc2n(C3CCC(=O)NC3=O)c3ncccc3c2c1)C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:31.34,wD:34.41,(3.31,-1.1,;3.31,-2.64,;4.64,-3.41,;5.97,-2.64,;7.31,-3.41,;8.64,-2.64,;9.97,-3.41,;11.31,-2.64,;12.64,-3.41,;13.97,-2.64,;13.97,-1.1,;15.31,-.33,;16.64,-1.1,;18.11,-.62,;18.51,.87,;17.42,1.95,;17.81,3.44,;19.3,3.84,;19.7,5.33,;20.39,2.75,;19.99,1.26,;21.08,.17,;19.01,-1.87,;20.54,-2.03,;21.17,-3.44,;20.26,-4.68,;18.73,-4.52,;18.11,-3.11,;16.64,-2.64,;15.31,-3.41,;1.97,-3.41,;.64,-2.64,;-.7,-3.41,;-2.03,-2.64,;-2.03,-1.1,;-.7,-.33,;.64,-1.1,;-3.36,-.33,;-4.83,-.8,;-5.73,.44,;-7.27,.44,;-8.04,-.89,;-7.27,-2.23,;-9.58,-.89,;-10.49,.35,;-11.95,-.12,;-11.95,-1.66,;-10.49,-2.14,;-13.04,-2.75,;-12.64,-4.24,;-13.73,-5.33,;-15.22,-4.93,;-15.62,-3.44,;-17.11,-3.04,;-18.19,-4.13,;-19.68,-3.73,;-20.77,-2.64,;-21.17,-4.13,;-14.53,-2.35,;-4.83,1.69,;-3.36,1.21,;-5.6,3.02,;-7.14,3.02,;-4.83,4.35,)|	InChI=1S/C47H54F2N10O5/c1-57(20-4-22-63-21-3-5-29-11-14-38-35(23-29)34-6-2-18-51-44(34)59(38)39-15-16-41(60)55-46(39)62)26-31-9-12-33(13-10-31)58-27-36(42(56-58)43(48)49)53-45(61)37-28-64-47(54-37)32-17-19-50-40(24-32)52-25-30-7-8-30/h2,6,11,14,17-19,23-24,27-28,30-31,33,39,43H,3-5,7-10,12-13,15-16,20-22,25-26H2,1H3,(H,50,52)(H,53,61)(H,55,60,62)	WCAUOXXGRBRELR-UHFFFAOYSA-N	648412	US11352350, Compound I-46	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 750							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648412	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648412&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733296	494493277							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370289	FC(F)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC2CC2)c1)C1CC[C@H](CNCCOCCOCCCc2ccc3n(C4CCC(=O)NC4=O)c4ncccc4c3c2)CC1 |r,wD:30.34,(-8.47,3.02,;-6.93,3.02,;-6.16,4.35,;-6.16,1.69,;-4.7,1.21,;-4.7,-.33,;-6.16,-.8,;-7.07,.44,;-8.61,.44,;-9.38,-.89,;-8.61,-2.23,;-10.92,-.89,;-11.82,.35,;-13.29,-.12,;-13.29,-1.66,;-11.82,-2.14,;-14.38,-2.75,;-13.98,-4.24,;-15.07,-5.33,;-16.55,-4.93,;-16.95,-3.44,;-18.44,-3.04,;-19.53,-4.13,;-21.02,-3.73,;-22.1,-2.64,;-22.5,-4.13,;-15.86,-2.35,;-3.36,-1.1,;-2.03,-.33,;-.7,-1.1,;-.7,-2.64,;.64,-3.41,;1.97,-2.64,;3.31,-3.41,;4.64,-2.64,;5.97,-3.41,;7.31,-2.64,;8.64,-3.41,;9.97,-2.64,;11.31,-3.41,;12.64,-2.64,;13.97,-3.41,;15.31,-2.64,;15.31,-1.1,;16.64,-.33,;17.98,-1.1,;19.44,-.62,;19.84,.87,;18.75,1.95,;19.15,3.44,;20.64,3.84,;21.03,5.33,;21.73,2.75,;21.33,1.26,;22.42,.17,;20.35,-1.87,;21.88,-2.03,;22.5,-3.44,;21.6,-4.68,;20.07,-4.52,;19.44,-3.11,;17.98,-2.64,;16.64,-3.41,;-2.03,-3.41,;-3.36,-2.64,)|	InChI=1S/C47H54F2N10O6/c48-43(49)42-36(54-45(61)37-28-65-47(55-37)32-15-17-51-40(24-32)53-26-31-5-6-31)27-58(57-42)33-10-7-30(8-11-33)25-50-18-20-64-22-21-63-19-2-3-29-9-12-38-35(23-29)34-4-1-16-52-44(34)59(38)39-13-14-41(60)56-46(39)62/h1,4,9,12,15-17,23-24,27-28,30-31,33,39,43,50H,2-3,5-8,10-11,13-14,18-22,25-26H2,(H,51,53)(H,54,61)(H,56,60,62)	IYPXIGBFZLQZGL-UHFFFAOYSA-N	648413	US11352350, Compound I-47	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 750							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648413	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648413&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733641	494493278							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370290	Cn1c2c(CCCOC3CCN(C[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)CC3)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:13.12,wD:16.19,(11.74,.8,;12.14,2.29,;11.23,3.54,;9.7,3.7,;8.93,2.36,;7.39,2.36,;6.62,1.03,;5.08,1.03,;4.31,-.3,;5.08,-1.64,;4.31,-2.97,;2.77,-2.97,;2,-4.31,;.46,-4.31,;-.31,-5.64,;-1.85,-5.64,;-2.62,-4.31,;-1.85,-2.97,;-.31,-2.97,;-4.16,-4.31,;-5.06,-3.06,;-6.53,-3.54,;-7.62,-2.45,;-7.22,-.96,;-5.73,-.56,;-8.31,.13,;-8.31,1.67,;-9.77,2.15,;-10.68,.9,;-9.77,-.35,;-12.22,.9,;-12.99,-.43,;-14.53,-.43,;-15.3,.9,;-14.53,2.23,;-15.3,3.57,;-16.84,3.57,;-17.61,4.9,;-17.61,6.44,;-18.94,5.67,;-12.99,2.23,;-6.53,-5.08,;-5.06,-5.55,;-7.86,-5.85,;-9.19,-5.08,;-7.86,-7.39,;2,-1.64,;2.77,-.3,;9.08,5.1,;9.98,6.35,;11.51,6.19,;12.14,4.78,;13.6,4.31,;14.94,5.08,;16.27,4.31,;17.61,5.08,;17.61,6.62,;18.94,7.39,;16.27,7.39,;14.94,6.62,;13.6,7.39,;13.6,2.77,;14.94,2,)|	InChI=1S/C45H54F2N10O6/c1-54-40-29(4-2-6-35(40)57(45(54)61)36-13-14-38(58)52-43(36)60)5-3-21-62-32-16-19-55(20-17-32)24-28-9-11-31(12-10-28)56-25-33(39(53-56)41(46)47)50-42(59)34-26-63-44(51-34)30-15-18-48-37(22-30)49-23-27-7-8-27/h2,4,6,15,18,22,25-28,31-32,36,41H,3,5,7-14,16-17,19-21,23-24H2,1H3,(H,48,49)(H,50,59)(H,52,58,60)	UCUUIRBTIKTRHU-UHFFFAOYSA-N	648414	US11352350, Compound I-48	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648414	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648414&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733773	494493279							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370291	Cn1c2c(CCCOCCN3CCN(C[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)CC3)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:15.14,wD:18.21,(13.92,-3.21,;15.01,-2.12,;14.69,-.61,;13.36,.16,;12.02,-.61,;10.69,.16,;9.36,-.61,;8.02,.16,;6.69,-.61,;5.36,.16,;4.02,-.61,;4.02,-2.15,;2.69,-2.92,;1.36,-2.15,;.02,-2.92,;-1.31,-2.15,;-2.65,-2.92,;-3.98,-2.15,;-3.98,-.61,;-2.65,.16,;-1.31,-.61,;-5.31,.16,;-6.78,-.32,;-7.68,.93,;-9.22,.93,;-9.99,-.41,;-9.22,-1.74,;-11.53,-.41,;-12.44,.84,;-13.9,.36,;-13.9,-1.18,;-12.44,-1.65,;-14.99,-2.26,;-14.59,-3.75,;-15.68,-4.84,;-17.17,-4.44,;-17.57,-2.96,;-19.06,-2.56,;-20.14,-3.65,;-21.63,-3.25,;-22.72,-2.16,;-23.12,-3.65,;-16.48,-1.87,;-6.78,2.17,;-5.31,1.7,;-7.55,3.51,;-9.09,3.51,;-6.78,4.84,;1.36,-.61,;2.69,.16,;13.36,1.7,;14.69,2.47,;16.03,1.7,;16.03,.16,;17.17,-.87,;18.66,-.47,;19.75,-1.56,;21.23,-1.16,;21.63,.32,;23.12,.72,;20.54,1.41,;19.06,1.01,;17.97,2.1,;16.54,-2.28,;17.31,-3.61,)|	InChI=1S/C46H57F2N11O6/c1-55-41-31(4-2-6-36(41)59(46(55)63)37-13-14-39(60)53-44(37)62)5-3-22-64-23-21-56-17-19-57(20-18-56)26-30-9-11-33(12-10-30)58-27-34(40(54-58)42(47)48)51-43(61)35-28-65-45(52-35)32-15-16-49-38(24-32)50-25-29-7-8-29/h2,4,6,15-16,24,27-30,33,37,42H,3,5,7-14,17-23,25-26H2,1H3,(H,49,50)(H,51,61)(H,53,60,62)	IWUAQFWTBYNQRV-UHFFFAOYSA-N	648415	US11352350, Compound I-58	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648415	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648415&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733649	494493280							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370292	Cn1c2cc(CN3CCN(CCO[C@H]4C[C@@H](C4)NC[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)CC3)ccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:19.19,13.12,wD:22.26,15.17,(20.59,-2.29,;20.19,-.8,;18.72,-.33,;17.39,-1.1,;16.06,-.33,;14.72,-1.1,;13.39,-.33,;12.06,-1.1,;10.72,-.33,;10.72,1.21,;9.39,1.98,;8.05,1.21,;6.72,1.98,;5.39,1.21,;4.99,-.27,;3.5,.12,;3.9,1.61,;2.17,-.65,;.83,.12,;-.5,-.65,;-.5,-2.19,;-1.83,-2.96,;-3.17,-2.19,;-3.17,-.65,;-1.83,.12,;-4.5,-2.96,;-5.97,-2.48,;-6.87,-3.73,;-8.41,-3.73,;-9.18,-2.39,;-8.41,-1.06,;-10.72,-2.39,;-11.63,-1.15,;-13.09,-1.62,;-13.09,-3.16,;-11.63,-3.64,;-14.42,-3.93,;-14.42,-5.47,;-15.76,-6.24,;-17.09,-5.47,;-17.09,-3.93,;-18.43,-3.16,;-19.76,-3.93,;-21.09,-3.16,;-21.86,-1.83,;-22.63,-3.16,;-15.76,-3.16,;-5.97,-4.97,;-4.5,-4.5,;-6.74,-6.31,;-8.28,-6.31,;-5.97,-7.64,;12.06,1.98,;13.39,1.21,;16.06,1.21,;17.39,1.98,;18.72,1.21,;20.19,1.69,;20.59,3.18,;22.07,3.58,;22.47,5.06,;21.38,6.15,;21.78,7.64,;19.9,5.75,;19.5,4.27,;18.01,3.87,;21.09,.44,;22.63,.44,)|	InChI=1S/C48H60F2N12O6/c1-58-40-20-31(6-9-38(40)62(48(58)66)39-10-11-42(63)56-46(39)65)26-60-16-14-59(15-17-60)18-19-67-35-22-33(23-35)52-24-30-4-7-34(8-5-30)61-27-36(43(57-61)44(49)50)54-45(64)37-28-68-47(55-37)32-12-13-51-41(21-32)53-25-29-2-3-29/h6,9,12-13,20-21,27-30,33-35,39,44,52H,2-5,7-8,10-11,14-19,22-26H2,1H3,(H,51,53)(H,54,64)(H,56,63,65)	XWYCVSKYBMUVTR-UHFFFAOYSA-N	648416	US11352350, Compound I-59	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648416	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648416&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733776	494493281							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370293	CN(C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F)C[C@H]1CN(CC#Cc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CCO1 |r,wU:3.2,wD:37.41,6.9,(3.61,-1.87,;3.61,-3.41,;2.28,-4.18,;.95,-3.41,;-.39,-4.18,;-1.72,-3.41,;-1.72,-1.87,;-.39,-1.1,;.95,-1.87,;-3.05,-1.1,;-4.52,-1.57,;-5.42,-.33,;-6.96,-.33,;-7.73,-1.66,;-6.96,-3,;-9.27,-1.66,;-10.18,-.42,;-11.64,-.89,;-11.64,-2.43,;-10.18,-2.91,;-12.73,-3.52,;-12.33,-5.01,;-13.42,-6.1,;-14.91,-5.7,;-15.31,-4.21,;-16.8,-3.81,;-17.89,-4.9,;-19.37,-4.5,;-20.46,-3.41,;-20.86,-4.9,;-14.22,-3.12,;-4.52,.92,;-3.05,.44,;-5.29,2.25,;-6.83,2.25,;-4.52,3.58,;4.95,-4.18,;6.28,-3.41,;7.62,-4.18,;8.95,-3.41,;10.28,-4.18,;11.62,-3.41,;12.95,-2.64,;14.28,-1.87,;14.28,-.33,;15.62,.44,;16.95,-.33,;18.42,.15,;18.81,1.64,;20.3,2.03,;20.7,3.52,;19.61,4.61,;20.01,6.1,;18.12,4.21,;17.73,2.72,;16.24,2.33,;19.32,-1.1,;20.86,-1.1,;18.42,-2.34,;18.81,-3.83,;16.95,-1.87,;15.62,-2.64,;8.95,-1.87,;7.62,-1.1,;6.28,-1.87,)|	InChI=1S/C46H53F2N11O6/c1-55(24-33-25-57(18-19-64-33)17-3-4-28-9-12-36-38(20-28)56(2)46(63)59(36)37-13-14-40(60)53-44(37)62)23-30-7-10-32(11-8-30)58-26-34(41(54-58)42(47)48)51-43(61)35-27-65-45(52-35)31-15-16-49-39(21-31)50-22-29-5-6-29/h9,12,15-16,20-21,26-27,29-30,32-33,37,42H,5-8,10-11,13-14,17-19,22-25H2,1-2H3,(H,49,50)(H,51,61)(H,53,60,62)	RWNNAVZOIZRWRI-UHFFFAOYSA-N	648417	US11352350, Compound I-61	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648417	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648417&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			160748757	494493282							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370294	CN(CCCOCCCc1ccc2n(C3CCC(=O)NC3=O)c(=O)n(C)c2c1)C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:29.31,wD:32.38,(3.61,-1.1,;3.61,-2.64,;4.95,-3.41,;6.28,-2.64,;7.62,-3.41,;8.95,-2.64,;10.28,-3.41,;11.62,-2.64,;12.95,-3.41,;14.28,-2.64,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,;18.42,-3.11,;18.81,-4.6,;16.95,-2.64,;15.62,-3.41,;2.28,-3.41,;.95,-2.64,;-.39,-3.41,;-1.72,-2.64,;-1.72,-1.1,;-.39,-.33,;.95,-1.1,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,)|	InChI=1S/C44H54F2N10O6/c1-53(18-4-20-61-19-3-5-27-10-13-34-36(21-27)54(2)44(60)56(34)35-14-15-38(57)51-42(35)59)24-29-8-11-31(12-9-29)55-25-32(39(52-55)40(45)46)49-41(58)33-26-62-43(50-33)30-16-17-47-37(22-30)48-23-28-6-7-28/h10,13,16-17,21-22,25-26,28-29,31,35,40H,3-9,11-12,14-15,18-20,23-24H2,1-2H3,(H,47,48)(H,49,58)(H,51,57,59)	OBGPFASAQFREKK-UHFFFAOYSA-N	648418	US11352350, Compound I-62	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648418	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648418&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			159944116	494493283							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370295	Cn1c2c(CCCOCC3CN(C[C@H]4CC[C@@H](CC4)n4cc(NC(=O)c5coc(n5)-c5ccnc(NCC6CC6)c5)c(n4)C(F)F)C3)cccc2n(C2CCC(=O)NC2=O)c1=O |r,wU:16.19,wD:13.12,(13.03,1.57,;14.12,.48,;13.8,-1.03,;12.46,-1.8,;11.13,-1.03,;9.8,-1.8,;8.46,-1.03,;7.13,-1.8,;5.79,-1.03,;4.46,-1.8,;4.06,-3.28,;2.58,-2.89,;1.24,-3.66,;-.09,-2.89,;-.09,-1.35,;-1.43,-.58,;-2.76,-1.35,;-2.76,-2.89,;-1.43,-3.66,;-4.09,-.58,;-5.56,-1.05,;-6.46,.19,;-8,.19,;-8.77,-1.14,;-8,-2.47,;-10.31,-1.14,;-11.22,-2.39,;-12.68,-1.91,;-12.68,-.37,;-11.22,.11,;-14.02,.4,;-14.02,1.94,;-15.35,2.71,;-16.68,1.94,;-16.68,.4,;-18.02,-.37,;-19.35,.4,;-20.69,-.37,;-21.46,-1.7,;-22.23,-.37,;-15.35,-.37,;-5.56,1.44,;-4.09,.96,;-6.33,2.77,;-7.87,2.77,;-5.56,4.11,;2.97,-1.4,;12.46,-3.34,;13.8,-4.11,;15.13,-3.34,;15.13,-1.8,;16.27,-.77,;17.76,-1.17,;18.85,-.08,;20.34,-.47,;20.74,-1.96,;22.23,-2.36,;19.65,-3.05,;18.16,-2.65,;17.07,-3.74,;15.65,.64,;16.42,1.97,)|	InChI=1S/C44H52F2N10O6/c1-53-39-29(4-2-6-34(39)56(44(53)60)35-13-14-37(57)51-42(35)59)5-3-17-61-24-28-21-54(22-28)20-27-9-11-31(12-10-27)55-23-32(38(52-55)40(45)46)49-41(58)33-25-62-43(50-33)30-15-16-47-36(18-30)48-19-26-7-8-26/h2,4,6,15-16,18,23,25-28,31,35,40H,3,5,7-14,17,19-22,24H2,1H3,(H,47,48)(H,49,58)(H,51,57,59)	XIZKUJVPOOFZDD-UHFFFAOYSA-N	648419	US11352350, Compound I-65	Interleukin-1 receptor-associated kinase 4	Homo sapiens		<50							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648419	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648419&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			161724303	494493284							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370296	CN(CCCCOCCCCc1cccc2n(C3CCC(=O)NC3=O)c(=O)n(C)c12)C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F |r,wU:31.33,wD:34.40,(.69,-.07,;.69,-1.61,;2.02,-2.38,;3.36,-1.61,;4.69,-2.38,;6.02,-1.61,;7.36,-2.38,;8.69,-1.61,;10.02,-2.38,;11.36,-1.61,;12.69,-2.38,;14.03,-1.61,;14.03,-.07,;15.36,.7,;16.69,-.07,;16.69,-1.61,;17.84,-2.64,;19.32,-2.24,;20.41,-3.33,;21.9,-2.93,;22.3,-1.45,;23.79,-1.05,;21.21,-.36,;19.72,-.76,;18.63,.33,;17.21,-4.05,;17.98,-5.38,;15.68,-3.89,;14.59,-4.98,;15.36,-2.38,;-.65,-2.38,;-1.98,-1.61,;-3.31,-2.38,;-4.65,-1.61,;-4.65,-.07,;-3.31,.7,;-1.98,-.07,;-5.98,.7,;-7.44,.22,;-8.35,1.47,;-9.89,1.47,;-10.66,.14,;-9.89,-1.2,;-12.2,.14,;-13.11,1.38,;-14.57,.91,;-14.57,-.63,;-13.11,-1.11,;-15.66,-1.72,;-15.26,-3.21,;-16.35,-4.3,;-17.84,-3.9,;-18.24,-2.41,;-19.72,-2.02,;-20.81,-3.1,;-22.3,-2.71,;-23.39,-1.62,;-23.79,-3.1,;-17.15,-1.33,;-7.44,2.71,;-5.98,2.24,;-8.21,4.05,;-9.75,4.05,;-7.44,5.38,)|	InChI=1S/C46H58F2N10O6/c1-55(21-4-6-23-63-22-5-3-8-31-9-7-10-36-41(31)56(2)46(62)58(36)37-17-18-39(59)53-44(37)61)26-30-13-15-33(16-14-30)57-27-34(40(54-57)42(47)48)51-43(60)35-28-64-45(52-35)32-19-20-49-38(24-32)50-25-29-11-12-29/h7,9-10,19-20,24,27-30,33,37,42H,3-6,8,11-18,21-23,25-26H2,1-2H3,(H,49,50)(H,51,60)(H,53,59,61)	GUPYXCUFARDEHX-UHFFFAOYSA-N	648420	US11352350, Compound I-67	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648420	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648420&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733845	494493285							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370297	CN(C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F)C1CCN(Cc2cccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c23)CC1 |r,wU:3.2,wD:6.9,(4.83,-3.86,;5.23,-2.38,;4.14,-1.29,;2.66,-1.69,;2.26,-3.17,;.77,-3.57,;-.32,-2.48,;.08,-.99,;1.57,-.6,;-1.81,-2.88,;-3.05,-1.98,;-4.3,-2.88,;-5.79,-2.48,;-6.19,-.99,;-5.1,.09,;-7.67,-.6,;-8.15,.87,;-9.69,.87,;-10.16,-.6,;-8.92,-1.5,;-11.65,-.99,;-12.05,-2.48,;-13.54,-2.88,;-14.63,-1.79,;-14.23,-.3,;-15.32,.78,;-16.81,.39,;-17.89,1.47,;-18.29,2.96,;-19.38,1.87,;-12.74,.09,;-3.82,-4.35,;-2.28,-4.35,;-4.91,-5.43,;-4.51,-6.92,;-6.4,-5.04,;6.72,-1.98,;7.12,-.49,;8.61,-.09,;9.69,-1.18,;11.18,-.78,;11.58,.71,;10.55,1.85,;11.03,3.32,;12.53,3.64,;13.56,2.49,;15.1,2.49,;16.17,3.6,;17.67,3.23,;18.74,4.33,;18.31,5.81,;19.38,6.92,;16.82,6.19,;15.75,5.08,;14.25,5.45,;15.58,1.03,;17.07,.63,;14.33,.12,;14.33,-1.42,;13.09,1.03,;9.3,-2.67,;7.81,-3.07,)|	InChI=1S/C44H53F2N11O5/c1-53(30-15-18-55(19-16-30)23-29-4-3-5-34-39(29)54(2)44(61)57(34)35-12-13-37(58)51-42(35)60)22-27-8-10-31(11-9-27)56-24-32(38(52-56)40(45)46)49-41(59)33-25-62-43(50-33)28-14-17-47-36(20-28)48-21-26-6-7-26/h3-5,14,17,20,24-27,30-31,35,40H,6-13,15-16,18-19,21-23H2,1-2H3,(H,47,48)(H,49,59)(H,51,58,60)	PZBSCIGRFYUWDF-UHFFFAOYSA-N	648421	US11352350, Compound I-75	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648421	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648421&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			146598367	494493286							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370298	CN(C[C@H]1CC[C@@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F)CC1CCN(Cc2cccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c23)CC1 |r,wU:3.2,wD:6.9,(4.59,-2.07,;4.2,-3.56,;2.71,-3.96,;1.62,-2.87,;.13,-3.27,;-.96,-2.18,;-.56,-.69,;.93,-.3,;2.02,-1.38,;-1.65,.4,;-3.19,.4,;-3.66,1.86,;-5.15,2.26,;-6.24,1.17,;-5.84,-.32,;-7.73,1.57,;-8.2,3.03,;-9.74,3.03,;-10.22,1.57,;-8.97,.66,;-11.71,1.17,;-12.1,-.32,;-13.59,-.72,;-14.68,.37,;-14.28,1.86,;-15.37,2.95,;-16.86,2.55,;-17.95,3.64,;-18.35,5.13,;-19.44,4.04,;-12.79,2.26,;-2.42,2.76,;-1.17,1.86,;-2.82,4.25,;-1.73,5.34,;-4.3,4.65,;5.29,-4.65,;6.77,-4.25,;7.17,-2.76,;8.66,-2.37,;9.75,-3.46,;11.24,-3.06,;11.63,-1.57,;10.6,-.42,;11.08,1.04,;12.59,1.36,;13.62,.22,;15.16,.22,;16.23,1.32,;17.72,.95,;18.79,2.06,;18.37,3.54,;19.44,4.65,;16.87,3.91,;15.8,2.8,;14.31,3.18,;15.63,-1.25,;17.12,-1.65,;14.39,-2.15,;14.39,-3.69,;13.14,-1.25,;9.35,-4.94,;7.86,-5.34,)|	InChI=1S/C45H55F2N11O5/c1-54(23-29-15-18-56(19-16-29)24-31-4-3-5-35-40(31)55(2)45(62)58(35)36-12-13-38(59)52-43(36)61)22-28-8-10-32(11-9-28)57-25-33(39(53-57)41(46)47)50-42(60)34-26-63-44(51-34)30-14-17-48-37(20-30)49-21-27-6-7-27/h3-5,14,17,20,25-29,32,36,41H,6-13,15-16,18-19,21-24H2,1-2H3,(H,48,49)(H,50,60)(H,52,59,61)	CJQLXWDSDQRRBN-UHFFFAOYSA-N	648422	US11352350, Compound I-76	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 75							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648422	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648422&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733887	494493287							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370299	FC(F)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC2CC2)c1)[C@H]1CC[C@H](CNCCOCCOCCCc2ccc3c(c2)n(C2CCC(=O)NC2=O)c2ncccc32)CC1 |r,wU:27.30,wD:30.34,(-6.16,-6.71,;-6.93,-5.38,;-8.47,-5.38,;-6.16,-4.04,;-4.7,-3.57,;-4.7,-2.03,;-6.16,-1.55,;-7.07,-2.8,;-8.61,-2.8,;-9.38,-1.46,;-8.61,-.13,;-10.92,-1.46,;-11.82,-2.71,;-13.29,-2.23,;-13.29,-.69,;-11.82,-.22,;-14.38,.4,;-13.98,1.88,;-15.07,2.97,;-16.55,2.57,;-16.95,1.09,;-18.44,.69,;-19.53,1.78,;-21.02,1.38,;-22.5,1.78,;-22.1,.29,;-15.86,-0,;-3.36,-1.26,;-3.36,.28,;-2.03,1.05,;-.7,.28,;.64,1.05,;1.97,.28,;3.31,1.05,;4.64,.28,;5.97,1.05,;7.31,.28,;8.64,1.05,;9.97,.28,;11.31,1.05,;12.64,.28,;13.97,1.05,;15.31,.28,;15.31,-1.26,;16.64,-2.03,;17.98,-1.26,;17.98,.28,;16.64,1.05,;19.44,.76,;19.84,2.25,;18.75,3.34,;19.15,4.82,;20.64,5.22,;21.03,6.71,;21.73,4.13,;21.33,2.65,;22.42,1.56,;20.35,-.49,;21.88,-.65,;22.5,-2.05,;21.6,-3.3,;20.07,-3.14,;19.44,-1.73,;-.7,-1.26,;-2.03,-2.03,)|	InChI=1S/C47H54F2N10O6/c48-43(49)42-36(54-45(61)37-28-65-47(55-37)32-15-17-51-40(24-32)53-26-31-5-6-31)27-58(57-42)33-10-7-30(8-11-33)25-50-18-20-64-22-21-63-19-2-3-29-9-12-34-35-4-1-16-52-44(35)59(39(34)23-29)38-13-14-41(60)56-46(38)62/h1,4,9,12,15-17,23-24,27-28,30-31,33,38,43,50H,2-3,5-8,10-11,13-14,18-22,25-26H2,(H,51,53)(H,54,61)(H,56,60,62)	IZUSOLSVQNPJIE-UHFFFAOYSA-N	648423	US11352350, Compound I-81	Interleukin-1 receptor-associated kinase 4	Homo sapiens		>1000							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648423	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648423&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			158854016	494493288							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370300	FC(F)c1nn(cc1NC(=O)c1coc(n1)-c1ccnc(NCC2CC2)c1)[C@H]1CC[C@H](CNCCOCCOCCCc2ccnc3n(C4CCC(=O)NC4=O)c4ccccc4c23)CC1 |r,wU:27.30,wD:30.34,(-13.42,-6.02,;-12.33,-7.11,;-12.73,-8.6,;-10.84,-6.71,;-9.59,-7.62,;-8.35,-6.71,;-8.82,-5.25,;-10.36,-5.25,;-11.45,-4.16,;-11.05,-2.67,;-9.57,-2.27,;-12.14,-1.58,;-13.68,-1.58,;-14.16,-.12,;-12.91,.79,;-11.67,-.12,;-13.31,2.27,;-14.65,3.04,;-14.65,4.58,;-13.31,5.35,;-11.98,4.58,;-10.64,5.35,;-10.64,6.89,;-9.31,7.66,;-7.77,7.66,;-8.54,9,;-11.98,3.04,;-6.86,-7.11,;-5.77,-6.02,;-4.28,-6.42,;-3.89,-7.91,;-2.4,-8.31,;-1.31,-7.22,;.18,-7.62,;1.27,-6.53,;2.76,-6.93,;3.84,-5.84,;5.33,-6.24,;6.42,-5.15,;7.91,-5.55,;9,-4.46,;10.48,-4.86,;11.57,-3.77,;13.06,-4.17,;14.15,-3.08,;13.75,-1.59,;12.26,-1.19,;11.57,.18,;12.34,1.52,;11.57,2.85,;12.34,4.18,;13.88,4.18,;14.65,5.52,;14.65,2.85,;13.88,1.52,;14.65,.18,;10.04,-.06,;8.85,.91,;7.41,.36,;7.17,-1.16,;8.37,-2.13,;9.8,-1.58,;11.18,-2.28,;-4.97,-9,;-6.46,-8.6,)|	InChI=1S/C47H54F2N10O6/c48-43(49)42-35(54-45(61)36-28-65-47(55-36)32-16-17-51-39(24-32)53-26-30-7-8-30)27-58(57-42)33-11-9-29(10-12-33)25-50-19-21-64-23-22-63-20-3-4-31-15-18-52-44-41(31)34-5-1-2-6-37(34)59(44)38-13-14-40(60)56-46(38)62/h1-2,5-6,15-18,24,27-30,33,38,43,50H,3-4,7-14,19-23,25-26H2,(H,51,53)(H,54,61)(H,56,60,62)	BXUNTMXAJVJZMT-UHFFFAOYSA-N	648424	US11352350, Compound I-92	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 300							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648424	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648424&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			166733327	494493289							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1370301	CN(C[C@H]1CC[C@H](CC1)n1cc(NC(=O)c2coc(n2)-c2ccnc(NCC3CC3)c2)c(n1)C(F)F)C[C@@H]1CN(CCCc2ccc3n(C4CCC(=O)NC4=O)c(=O)n(C)c3c2)CCO1 |r,wU:37.41,wD:3.2,6.9,(3.61,-1.1,;3.61,-2.64,;2.28,-3.41,;.95,-2.64,;.95,-1.1,;-.39,-.33,;-1.72,-1.1,;-1.72,-2.64,;-.39,-3.41,;-3.05,-.33,;-4.52,-.8,;-5.42,.44,;-6.96,.44,;-7.73,-.89,;-6.96,-2.23,;-9.27,-.89,;-10.18,.35,;-11.64,-.12,;-11.64,-1.66,;-10.18,-2.14,;-12.73,-2.75,;-12.33,-4.24,;-13.42,-5.33,;-14.91,-4.93,;-15.31,-3.44,;-16.8,-3.04,;-17.89,-4.13,;-19.37,-3.73,;-20.46,-2.64,;-20.86,-4.13,;-14.22,-2.35,;-4.52,1.69,;-3.05,1.21,;-5.29,3.02,;-6.83,3.02,;-4.52,4.35,;4.95,-3.41,;6.28,-2.64,;7.62,-3.41,;8.95,-2.64,;10.28,-3.41,;11.62,-2.64,;12.95,-3.41,;14.28,-2.64,;14.28,-1.1,;15.62,-.33,;16.95,-1.1,;18.42,-.62,;18.81,.87,;20.3,1.26,;20.7,2.75,;19.61,3.84,;20.01,5.33,;18.12,3.44,;17.73,1.95,;16.24,1.56,;19.32,-1.87,;20.86,-1.87,;18.42,-3.11,;18.81,-4.6,;16.95,-2.64,;15.62,-3.41,;8.95,-1.1,;7.62,-.33,;6.28,-1.1,)|	InChI=1S/C46H57F2N11O6/c1-55(24-33-25-57(18-19-64-33)17-3-4-28-9-12-36-38(20-28)56(2)46(63)59(36)37-13-14-40(60)53-44(37)62)23-30-7-10-32(11-8-30)58-26-34(41(54-58)42(47)48)51-43(61)35-27-65-45(52-35)31-15-16-49-39(21-31)50-22-29-5-6-29/h9,12,15-16,20-21,26-27,29-30,32-33,37,42H,3-8,10-11,13-14,17-19,22-25H2,1-2H3,(H,49,50)(H,51,61)(H,53,60,62)	ZHYPELBSLFFEAM-UHFFFAOYSA-N	648425	US11352350, Compound I-94	Interleukin-1 receptor-associated kinase 4	Homo sapiens		 300							US Patent		10.7270/Q2125XTF		aid1963325	US11352350	Mainolfi, N; Ji, N; Kluge, AF; Weiss, MM; Zhang, Y; Zheng, X	6/7/2022	4/3/2024	Kymera Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=648425	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5405&target=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=648425&enzyme=Interleukin-1+receptor-associated+kinase+4&column=ki&startPg=0&Increment=50&submit=Search			164155023	494493290							1	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS	8DKS,8UCC,8UCB,8TX0,8TVN,8TVM,6EGA,6EG9,4RMZ,2NRY,2NRU,9R9K,9R9J,9R9G,7QG5,7QG3,7QG2,6TIA,6TI8,6THZ,6THX,6THW,8W3X,8W3W,7QG1,6RFJ,6RFI,6F3I,5UIU,5UIT,5UIS,5UIR,5UIQ,9PSU,9PST,9PSS,9NA6,9NA5,9NA4,9NA3,9NA2,6O8U,6MOM,5T1T,5T1S,5KX8,5KX7,5K7I,5K7G,5K76,5K75,5K72,4ZTN,4ZTM,4ZTL,4YP8,4YO6,4XS2,2OID,2OIC,2OIB,4Y73,6UYA,6O9D,6O95,6O94,7C2V,8BR5,2O8Y,6N8G,7C2W,6F3G,6F3E,6F3D,3MOP	Interleukin-1 receptor-associated kinase 4	IRAK4_HUMAN	Q9NWZ3	Q69FE1 Q8TDF7 Q9Y589